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ABSTRACT
Sommakia, Salah Ph.D., Purdue University, December 2013. Eﬀects of Dipcoated ﬁlms on the Properties of Implantable Intracortical Microelectrodes.
Major Professor: Kevin J. Otto and Jenna L. Rickus.
The successful clinical use of implantable intracortical microelectrodes (ICMs)
to treat certain types of deafness, blindness, and paralysis is limited by a reactive tissue response (RTR) of the brain. This RTR culminates in the formation
of a tight glial scar and a loss of neuronal density around implanted ICMs,
and is accompanied by a decrease in signal to noise ratio and an increase in
impedance. While no comprehensive mechanistic understanding of the underlying biology is currently agreed upon in the ﬁeld, a general consensus exists
around a highly volatile acute RTR phase. During this acute phase, the electrical properties of ICMs do not always coincide with cellular responses, and the
extent of initial injury appears to greatly inﬂuence the degree of the chronic
RTR. While many electrode modiﬁcations and treatments are eﬀective in the
short term, the chronic RTR appears impervious to most interventions.
To better understand the acute phase of the RTR, this dissertation aims to
investigate the eﬀects of various dip-coated biomolecules on the electrical properties of ICMs and cellular responses to microscale ICM-like foreign bodies. We
ﬁrst present an examination of silica sol-gel thin ﬁlms as a potential biomolecule
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delivery platform which does not adversely aﬀect the electrical properties of
ICMs. The second study shows that adsorbed proteins, thought to play an important role in modulating the RTR, cause signiﬁcant increases in electrode
impedance. In contrast to prevalent electrical models of the electrode tissue
interface which assume purely resistive impedance changes due to adsorbed
proteins, our results show both resistive and capacitive changes. We also show
that increases in impedance related to protein adsorption can be prevented by
dip coating ICMs in an aqueous solution of high molecular weight polyethylene
glycol (PEG). We then describe a method to clean electrode sites using direct
current (DC) biasing, showing that DC biasing is capable of restoring electrode
impedance following exposure to enzymatic cleaning solutions, proteins, phantom brains, and actual brain tissue. The ﬁnal study in an in vitro mixed primary cortical cell culture model shows that lipopolysaccharide (LPS), a wellknown ligand to toll-like 4 (TL4) receptors, dip-coated onto segments of metal
microwire, can simulate localized inﬂammation around an implanted ICM. We
observe elevated activation of glial cells in interface regions, and extending into
more distant regions. This elevation in glial responses is not accompanied by a
decrease in neuronal density. We additionally show that microwire dip-coated
with a mixture of LPS and PEG exhibits signiﬁcantly lower microglial and astrocyte responses.
These ﬁndings highlight the importance of adsorbed proteins, some of which
are implicated in aggravating the reactive tissue response, but which we show

xvi
can result in signiﬁcant increases in electrode impedance before the RTR even
begins. These impedance changes can be prevented through the use of dipcoated PEG. Our cell culture data presents further evidence for the attractiveness of TL4 receptors as a target for intervention, and suggests that the loss
of neuronal density observed in vivo is better explained by other mechanisms
following device insertion than pure glial activation.

1

1. RATIONALE AND SIGNIFICANCE
Many traumatic injuries and degenerative diseases are currently incurable, but
can be treated with varying degrees of success by implantable neural microelectrodes in the central nervous system. For example, Spinal Cord Injuries
(SCI) occur at a rate of 11,000 cases per year in the U.S. and currently aﬀect
up to 400,000 Americans [Berkowitz et al., 1998] and are extremely costly to
treat. Additionally, there are about 3.3 million Americans suﬀering from visual
impairment [In et al., 2004] and about 750,000 aﬀected by severe to profound
hearing impairment [Mohr et al., 2001]. The lack of successful cures for sensory
impairments and CNS injuries has stimulated research into using external devices to interface with the remaining healthy parts of the CNS, to create either
a brain machine interface [Nicolelis et al., 2003] or a neural prosthesis capable of restoring or enhancing lost neural function. Such devices has been used
with varying degrees of success to treat blindness [Maynard, 2001] and deafness [Lenarz et al., 2006, Loeb, 1990] and to enable bladder and muscle control
in paralyzed patients [Grill, 2000]. For devices interfacing with the central nervous system, two distinct approaches exist. The ﬁrst approach is to use surface
electrodes that rest on top of the brain surface [Leuthardt et al., 2004]. Surface
electrodes, however, are limited by the organization of cortical cells into dis-
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tinct layers and columns within those layers, placing target neuron populations
deep within the cortex. The second approach employs penetrating intracortical
electrodes which oﬀer unique abilities to target deep neuron populations with
high speciﬁcity [Normann et al., 1999, Otto et al., 2005]. While intracortical implants have been shown to be feasible, they are unreliable in chronic settings.
They encounter decreased signal to noise ratios (SNR), increased impedance
and a loss of discrimination [Vetter et al., 2004]. The degradation in electrical characteristics of the electrode-tissue interface is correlated with a reactive
response of brain tissue. The trauma of insertion initiates a cascade of events
culminating in the formation of a glial scar around the electrode, isolating it
from the surrounding healthy brain tissue. Various treatments have been investigated to mitigate this reactive tissue response, but no completely eﬀective
solution has been found.

The state of the art in the ﬁeld holds that a highly volatile acute phase is
susceptible to various interventions, but that beneﬁcial eﬀects are typically lost
within a few weeks once the chronic response sets in. There is a lack of a detailed and comprehensive understanding of the relation between the biological
components of the reactive tissue response and the changes in electrical properties of the implanted ICM, which do not always exhibit a consistent correlation. Many current studies into neurointegrative interventions are performed
on non-functional electrodes for various reasons of cost-eﬀectiveness and con-
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venience, making it diﬃcult to draw solid and accurate conclusions as to the
eﬃcacy of such interventions. This dissertation will attempt to shed some light
on some of these unaddressed points. A background review of the literature will
be presented in Chapter 2, surveying common electrode designs and their application, and attempt to summarize current knowledge about the progression
of the reactive tissue response as well as various interventions. Chapter 3 will
discuss silica-sol gel thin ﬁlms as coatings for neural microelectrodes with potential bioactivity without adverse eﬀect on electrode properties. Chapter 4 will
discuss details of impedance changes to electrode properties following exposure
to a model protein, and demonstrate how such changes can be prevented by applying a dip-coated ﬁlm of high molecular weight polyethylene glycol (PEG). A
preliminary in vivo study will also be presented, investigating how impedance
increases in vivo can prevented by applying PEG topically into the brain and
examining the implications. Chapter 5 will describe a method of cleaning electrode sites using relatively long duration direct current (DC) pulsing, suitable
for acute experiments. Chapter 6 will investigate the cellular responses to ICMlike microscale foreign bodies in a primary mixed cortical cell culture model.
Using lipopolysaccharide (LPS) to induce microglial activation, we simulate localized inﬂammation without the presence of blood brain barrier injury, and
attempt to draw physiologically relevant conclusions from the behavior of the
various cell types. Chapter 7 will summarize and oﬀer conclusions, unanswered
questions, and potential future work.

4

2. BACKGROUND
2.1

Common Electrode Array Designs
Factors such as cost and availability guide the choice of electrode array, but

a basic understanding of each design’s advantages and limitations is essential
for long term studies, especially when the reactive tissue response to the implanted electrode is to be considered. Figure 2.1 shows examples of penetrating
intracortical electrode arrays under investigation for neural prosthetic applications.

(a) Microwire
Array; (b) Utah Electrode Array; (c) Michigan
adapted from Williams adapted from Normann et al. adapted from
et al. [2007]
[1999]
et al. [2004]

probe;
Vetter

Fig. 2.1. Examples of commonly used electrode arrays currently
under investigation for use in neural prosthetic applications

5
2.1.1 Microwire
Microwire neural electrodes have been used since 1958, when Strumwasser
reported the feasibility of using 80 µm diameter stainless steel wire for obtaining single neuron recordings lasting more than a week from awake, unrestrained animals [Strumwasser, 1958]. Current microwire-based electrodes
are usually made of a conducting material such as gold [Yuen and Agnew, 1995],
iridium [Liu et al., 1999], tungsten [Williams et al., 1999], or stainless steel [Nicolelis
et al., 2003]. The microwire is coated with an insulating material, leaving the
tip exposed to act the electrode site. They are usually arranged into arrays to
cover a larger cortical area. The electrode counts of commonly utilized arrays
have ranged from four [Yuen and Agnew, 1995] to more than 100 [Nicolelis et al.,
2003]. While microwire arrays are relatively easy to construct, they are prone to
bending during insertion, introducing uncertainty about the precise location of
the microwires within the cortex [Edell et al., 1992]. Size considerations mean
that blunt microwires, usually implanted in bundles [Cheung, 2007] can cause
unacceptable levels of neuron displacement during insertion. These limitations
necessitated the development of alternative electrode substrate materials and
fabrication methods, paving the way for the next generation of silicon arrays.

6
2.1.2 Micromachined silicon-based electrode arrays
Silicon micromachining techniques have enabled the uniform production of
microelectrodes with high electrode site counts and allow complex designs [Polikov et al., 2005], resulting in more design ﬂexibility to counter the problem
of the reactive tissue response. Photolithography methods applied to electrode
fabrication enable great control over electrode size, shape and spacing. Smaller
electrodes result in better spatial discrimination [Kipke et al., 2003] allowing
the design of more sensitive electrodes. Additionally, electrode spacing has
proven important in recent research into the eﬀect of electrode depth within the
brain on neural prosthetic control [Schwarz, 2004]. Among the many electrode
array designs tested, two designs have emerged as de facto standards within the
neural engineering community: the Utah electrode array (UEA), originally developed at the University of Utah, and the Michigan probe, originally developed
at the University of Michigan.

Utah electrode array
The UEA is an array of sharpened conductive silicon shanks, that is fabricated from a single block of silicon through repeated steps of doping and etching. The silicon shanks are individually isolated, with the electrode site at
the tip [Cheung, 2007]. The UEA has come a long way since Campbell et al.
[1991] demonstrated its feasibility as a neural prosthetic device in 1991. It has
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been recently employed in a BMI tested in a severely tetraplegic human patient [Hochberg et al., 2006]. A major drawback of the UEA is the location of
the electrode sites at the tip of the silicon shanks, restricting control over the
depth location of the electrode sites. Some attempts have been made to overcome this limitation through fabricating a UEA with graded shank lengths to
permit excitation and recording at diﬀerent depths [Badi et al., 2003].

Michigan array
The Michigan probe currently produced by the Center of Neural Communication Technology (CNCT) evolved from the original designs of Kensall Wise
at the University of Michigan [Wise et al., 1970]. The advantage of Michigan
probes is the reproducible fabrication of shanks with a high precision electrode
placement [Cheung, 2007]. This layout allows for research into the electrical
activity of diﬀerent layers in the cortex and for the precise marking of the location of the electrode sites within the cortex [Townsend et al., 2002]. This
kind of precise mapping of electrode location was not previously possible. While
acute recording and stimulation with Michigan probes have been shown to be
feasible [Hetke and Anderson, 2002, McConnell et al., 2007], there is interest
in developing chronic applications. The chronic response of brain tissue has
been studied extensively using Michigan probes. Many studies on treatments
for integrating implantable electrodes with neural tissue are conducted using
Michigan probes supplied by CNCT.
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2.2

Progression of the reactive tissue response
The reaction of CNS tissue to implanted devices is physiologically unique due

to the presence of the blood-brain barrier (BBB). The BBB consists of closely
packed endothelial cells surrounded by astrocytic processes. This layer protects the brain from biochemical ﬂuctuations in the periphery by restricting the
passage of certain molecules, while allowing the passage of nutrients and oxygen [Shoichet et al., 2008]. Chronic BBB injury has been pinpointed as a major
factor in the adverse brain tissue response to implanted microelctrodes[Saxena
et al., 2013]. The response of brain tissue to implanted electrodes is an aggregate of many sub-responses involving many cell types in the brain, including
glial cells, neurons, meningeal ﬁbroblasts and blood macrophages. Over all, the
tissue response can be divided into an acute and a chronic components. Figure
2.2 shows a hypothetical timeline of the response of various cell types in the
CNS to an implanted electrode.

2.2.1

Acute (initial) response

Vascular damage, edema, and biofouling
The cortex has a high vascular density with small capillaries forming dense
networks between larger, longitudinal vessels [Cavaglia et al., 2001]. The injury
process following electrode insertion into the brain begins with the inevitable
breach of the blood-brain barrier, releasing serum and blood cells into the in-
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Fig. 2.2. Projected timeline of cellular responses to implanted
electrodes in the CNS. Adapted from He and Bellamkonda [2008]
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jury site [Clark et al., 1994]. Studies performed in live brain slices show that
vascular damage in the CNS in response to electrode insertion can be classiﬁed
into four categories: ﬂuid displacement, vessel rupture, vessel severing and mechanical dragging by the device [Bjornsson et al., 2006]. Electrode insertion also
damages neurons and glial cells, causing the immediate accumulation of cellular and myelin debris at the injury site [Fawcett and Asher, 1999, Polikov et al.,
2005]. During insertion electrodes penetrate the meningeal surface carrying
meningeal cells into the brain and allowing for their migration along the electrode shank [Krueger et al., 1986]. Migrating ﬁbroblasts attempt to recreate
the glia limitans, a layer of tightly meshed astrocytic processes and ﬁbroblasts
separating neurons in the brain from the pia mater [Ramer et al., 2001].
Vascular damage results in clot formation. Platelets adhere to collagen ﬁbers
from the broken endothelium of the damaged blood vessels, forming the initial
hemostatic plug. They subsequently upregulate the high-aﬃnity platelet integrin αIIbβ, which mediates further platelet aggregation [Ruggeri, 2002]. Once
bound, platelets degranulate, releasing plasma coagulation factors which trigger the formation of a ﬁbrin clot [Standeven et al., 2005]. Activated platelets
also release signaling molecules such as platelet-derived growth factor (PDGF)
[Deuel and Huang, 1984, Heldin, 1992], transforming growth factor-β (TGFβ) [Assoian et al., 1983] and vascular endothelial growth factor (VEGF) [Mohle
et al., 1997, Papavassiliou et al., 1997]. These factors attract extravasated inﬂammatory blood-borne cells to the injury site, leading to the formation of brain
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edema [Klatzo, 1987, Schilling and Wahl, 1997, 1999, Wahl et al., 1988]. Local
edema increases pressure around the implantation site, resulting in the further
neuronal displacement [Polikov et al., 2005]. Extravasated proteins contribute
to the later inﬂammatory response; for example, thrombin has been suggested
as a trigger for microglia [Choi et al., 2003, Hanisch et al., 2004, Moller et al.,
2000] and astrocyte [Ehrenreich et al., 1993, Grabham and Cunningham, 1995,
Suidan et al., 1997] activation. Protein adsorption, contributes to the immune
response to implanted materials everywhere in the body, ultimately aﬀecting
device biocompatibility [Williams et al., 1985]. Adsorbed proteins have been
implicated in increasing the levels of activated glia, especially microglia, at the
device/tissue interface [Leung et al., 2008].

Activation of glial cells
Glial cells form the majority of the cells in brain, constituting about 75%
of the total brain volume [Purves et al., 1997]. Previously thought to only
provide structural support for neurons, glial cells have been found to provide
growth cues to neurons during development, control the chemical environment
in the brain and modulate electrical activity of neurons, among many other
functions [Kettenmann and Ransom, 2005]. The main glial cells involved in the
reactive tissue response to implanted electrodes that are discussed in this document are microglia and astrocytes. The exact details of glial activation are still
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under investigation, but the phenotypical transformations that they undergo
are well characterized.

Microglia While the question of the ontogeny of microglia is controversial,
the most prevalent view holds that they arise from the prenatal arrival of bloodborne monocytes into the CNS [Kaur et al., 2001]. Microglia roam the brain acting as pathological event sensors, performing multiple functions including activation, proliferation and migration to the injury site [Kreutzburg, 1996]. In the
absence of injury, ramiﬁed (resting) microglia exist in a highly branched state,
constituting 5-10% of the total number of glial cells in the brain [Ling, 1981].
Following injury microglia interact with various cytokines adsorbed onto the
implanted surface, as well as chemokines present in the vicinity of the injury
site, and undergo activation. Activation is mediated through many factors such
as ATP, toll-like receptor 4, and reactive oxygen species [Davalos et al., 2005,
Okun et al., 2011, Qin et al., 2005, Tanga et al., 2005]. Microglial activation
involves cell proliferation and the assumption of a compact ameboid morphology indistinguishable from macrophages [Fawcett and Asher, 1999]. Microglia
begin to perform functions similar to macrophages including phagocytosis of
foreign materials and upregulation of lytic enzymes to aid in the degradation
of the foreign materials [Polikov et al., 2005]. Analysis of the glial sheath ex
vivo around electrodes implanted in rat brains [Biran et al., 2005] and in vitro
in primary rat cortex cultures [Polikov et al., 2006] shows that microglia form
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the glial scar layer closest to the electrode surface, suggesting they are the ﬁrst
glial cell type to respond to implanted electrodes. They adhere to the surface of
the electrode and act as a source for proinﬂammatory cytokines, such as IL1-β
and TNF-α [Leung et al., 2008]. The accumulation of activated microglia may
amplify the cytokine production cascade. Attenuating the production of these
proinﬂammatory cytokines, either through prevention of microglial adhesion
or direct intervention in the inﬂammatory pathways, may be a key factor to
improving the neurointegration of chronically implanted electrode.

Astrocytes

Astrocytes comprise 30-65% of glial cells in the CNS [Nathaniel

and Nathaniel, 1981]. They possess a characteristic star shape with ﬁne cellular processes, comprised of 8-10nm diameter ﬁlaments of polymerized glial
ﬁbrillary acidic protein (GFAP), considered to be a speciﬁc marker for astrocytes [Eng, 1985]. Following injury, astrocytes assume a reactive phenotype,
undergoing dramatic biochemical and functional changes characterized by proliferation and hypertrophy through the upregulation of GFAP [Pekny and Nilsson, 2005]. This process is usually termed “reactive gliosis” [Norton et al., 1992].
Astrocyte activation initiates the chronic response and the formation of the glial
scar, discussed in the following section. Astrocytic phenotype transformation
also involves a switch from being conducive to neuronal growth towards being
inhibitory [Davies et al., 1996].
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2.2.2

Chronic (sustained) response

Formation of glial scar
The most prominent manifestation of the long-term response to implantable
electrodes in the CNS is the formation of the glial scarâĂŤthe analogue of the
ﬁbrous encapsulation tissue observed in non-CNS tissue in response to nondegradable materials [Polikov et al., 2005]. In non-CNS tissue, ﬁbrous encapsulation occurs when macrophages encounter a large non-degradable object that
they are incapable of phagocytosing. In response, macrophages fuse into multinucleated foreign body giant cells and continue to secrete degradative factors
such as superoxides and free radicals. In the CNS, the equivalent cells are
microglia. Upon failing to phagocytose the implanted electrode, they persist
in an activated state, further increasing neuronal damage). The main component of the glial scar, however, is not activated microglia, but reactive astrocytes bound by tight and gap junctions [Edell et al., 1992, Fawcett and Asher,
1999, Turner et al., 1999]. Pathological production of extracellular matrix components, such as laminin, collagen, and proteoglycans generally accompanies
—and mediates— the formation of the glial scar in spinal cord and traumatic
brain injury [Asher et al., 2001, Fitch and Silver, 2008, Liesi and Kauppila,
2002, McKeon et al., 1999]. A persistent glial scar forms as a response to the
continued presence of the electrode within the brain [Biran et al., 2005, Rousche
et al., 2001]. The in vivo formation of the glial scar exhibits great variabil-
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ity between experiments. Even within the same experiment, some shanks of
multi-shank probes elicit limited scarring while other shanks result in extensive scarring [Edell et al., 1992, Rousche and Normann, 1998]. The extent of
the glial scarring is dependent on the amount of the initial damage done during
insertion [Szarowski et al., 2003]. The chronic glial scar around an implanted
electrode at 2 weeks is composed of reactive astrocytes 500–600 µm from the
implanted electrode at about 2 weeks. Over time the area of the scar region decreases, but cells become more compact and tightly bound by weeks 6 to 12, with
a thickness of 50–100 µm around the implant [Szarowski et al., 2003, Turner
et al., 1999]. An in vitro model produced by Polikov et al. [2006] demonstrated
a similar pattern of glial scar formation around microwires. The formation of
the glial scar has been implicated as the cause for the dramatic increase of the
impedance of implanted electrodes [Edell et al., 1992, Otto et al., 2006, Williams
et al., 1999]. Observations of the total impedance magnitude of implanted electrodes over time reveal a marked jump at about 1 week post-implantation [Otto
et al., 2006, Williams et al., 2007], displaying close temporal correlation to the
formation of the tight junctions between the astrocytes in the glial scar. Proteins secreted by reactive astrocytes also play an important role in the ensuing
neuronal response to electrode implantation. For example, reactive astrocytes
also simultaneously produce type IV collagen and α1 laminin, leading to the formation of a basement membrane which blocks the neuron-outgrowth-promoting
eﬀects of γ1 laminin secreted by resting astrocytes [Liesi and Kauppila, 2002].
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Fig. 2.3. Immunoﬂuorescence images showing some components
of a glial scar around an electrode implanted in the cortex of a
rat. Left image shows a layer of activated microglia; center image
shows a layer of reactive astrocytes; right image shows decreased
neuronal density. Scale bar = 100 µm. Modiﬁed from Biran et al.
[2005]

Figure 2.3 shows a representation of cellular distributions around an implanted
electrodes 4 weeks after implantation, demonstrating minimally overlapping
layers of activated microglia and reactive astrocytes, and a decline in neuronal
density around the electrode.

Loss of neuronal density
The formation of the glial scar is accompanied by a loss of neural density in
the vicinity of the implanted electode [Biran et al., 2005] and a decline in the
recorded SNR over time [Vetter et al., 2004]. Reports of the size of this area
of depleted neuronal density vary from about 1 µm to over 100 µm [Stensaas
and Stensaas, 1976, Turner et al., 1999]. One explanation for this phenomenon
is that insertion trauma causes neuronal death, leading some researchers to
coin the term “kill zone”[Edell et al., 1992]. This explanation has been disputed
by studies conﬁrming the presence of neurons in the vicinity of the implanted
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(a) Decline of SNR over time

(b) Gradual increase in impedance
magnitude over time

Fig. 2.4. Decline in electrical properties of implanted electrodes
over time. Adapted from Vetter et al. [2004]

electrode and the ability to record neural signals during the ﬁrst week postimplantation [Biran et al., 2005, Williams et al., 1999]. This ﬁnding implies
that neurons survive throughout the initial response. Several studies have reported a gradual decline in signal strength over time [Liu et al., 1999, Nicolelis,
2003, Vetter et al., 2004], suggesting that a gradual remodeling of neural tissue around the implanted electrode –where neurons are slowly displaced by
migrating reactive microglia and astrocytes– is responsible for the decline in
signal quality. Figure 2.4 shows the progressive decline of electrical properties of implanted electrodes. The left panel (Figure 2.4(a)) shows the decline in
recorded SNR over time, while the right panel (Figure 2.4(b)) shows the gradual
increase in impedance magnitude, with an abrupt increase between 7 and 10
days post-implantation.
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2.3

Current approaches to improving electrode integration
Neurointegrative treatments can be implemented as a preventative method

prior to electrode implantation. Preventative measures include electrode design
elements, coating electrodes with conductive materials to improve their ability
to deliver electrical charge beyond the glial scar or coating with biomimetic materials to suppress or eliminate the reactive tissue response. Neurointegrative
treatments can also be applied during the implantation procedure (through local or intravenous delivery of anti-inﬂammatory drugs) or post-implantation
by applying electrical ﬁelds of various strength to either guide neuron growth
towards the electrode or to break up the disruptive glial scar layer. These approaches will be discussed in detail in the following sections.

2.3.1

Electrode design elements

One of the strongest eﬀorts in current neuroprosthetic device development
is research into ultrasmall electrodes and highly ﬂexible materials to address
mechanical mismatch between implanted electrodes and brain tissue. It has
been shown that reducing electrode size and surface area results in smaller
glial scars and improved neuronal integration [Kozai et al., 2012a, Seymour and
Kipke, 2007, Skousen et al., 2011]. Smaller and more ﬂexible electrodes have
their disadvantages, most notable that they are diﬃcult to insert through the
pia and into the brain. Some potential solutions have been to use degradable
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insertion shuttles [Kozai and Kipke, 2009], mechanically adaptive electrode materials [Harris et al., 2011] or a combination of both [Lewitus et al., 2011]. Dissolvable insertion shuttles, however, might subject their ﬂexible cargo to substantial ﬂuid forces [Rakuman et al., 2013]. Recent ﬁndings have suggested
that material density might be as important as its stiﬀness [Lind et al., 2013].

2.3.2

Electrode enhancing treatments

The need for higher currents to stimulate neurons in the brain, in addition to
the formation of the glial scar and the accompanying increase in impedance, necessitated the development of electrode materials capable of delivering higher
amounts of electrical charge per unit surface area , a property known as charge
injection capacity [Cogan, 2008]. A trade-oﬀ exists between the selectivity of
neural electrodes (the ability to record from and stimulate a small number of
neurons) and their sensitivity (the ability to pick up weak neural activity in
the presence of thermal noise and signal loss through shunt pathways) [Ludwig
et al., 2006]. A common approach to address this issue is to modify the electrode
surface by adding a layer of a diﬀerent material to either increase the charge injection capacity or increase the surface area to lower the impedance. The goal of
such modiﬁcations is to increase the sensitivity while retaining a small enough
electrode size to maintain acceptable sensitivity. The most prevalent method to
enhance an electrode’s electrical properties is the use of conductive polymers.
Poly(3,4-ethylenedioxythiophene) (PEDOT) codeposited with Polystyrene Sul-
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fonate (PSS) onto electrode sites of Michigan probes results in an electrochemically stable, fuzzy ﬁlm with an impedance two orders of magnitude lower than
native electrodes [Cui and Martin, 2003, Cui and Zhou, 2007, Yang and Martin, 2004]. More recent research has further validated the use of PEDOT as a
micro-neural material for electrostimulation [Wilks et al., 2009], allowing for
miniaturization of electrode site size without sacriﬁcing sensitivity [Ludwig
et al., 2011]. The superior electrical properties and electrochemical stability
of PEDOT have made it a favorite candidate among the conductive polymers for
use in neural electrodes. Chronic tests of PEDOT in vivo show that PEDOTcoated sites outperform uncoated electrode sites in SNR metrics(Ludwig et al.,
2006). PEDOT-coated electrodes, however, exhibit impedance ﬂuctuations, attributable to the delamination of the ﬁlms from the electrode sites, leading to
the investigation of more stable PEDOT ﬁlms, such as PEDOT nanotubes [Abidian and Martin, 2009, Abidian et al., 2009, 2010]. PEDOT can also be polymerized in living neural tissue, depositing in the extracellular spaces and forming
‘ﬁngers’ which protrude far enough into the neural tissue to potentially extend
past any ﬁbrous tissue attempting to encapsulate the electrode [RichardsonBurns et al., 2007]. Some studies have attempted to decorate PEDOT ﬁlms with
biological molecules to further improve its integration with neural tissue [Cui
and Martin, 2003, Green et al., 2009]. While these treatments achieve improved
electrical properties in vivo, they are typically limited to the electrode site area.
In the most common electrode designs, electrode sites cover only a small por-
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tion of the total area of electrode. Other neruointegrative treatments focus on
covering the entire electrode surface as described in the following sections.

2.3.3

Biomimetic coatings

There are two main approaches to designing coatings that mimic the local
ECM in the CNS. The ﬁrst approach aims to encourage neuron attachment to
the electrode, while the second approach aims to manipulate glial cells in an
attempt to attenuate glial scar formation [Polikov et al., 2005].
Several studies have attempted to create surfaces more conducive to neural
growth by incorporating or immobilizing cell adhesion molecules. A common
approach is the use of multipeptide fragments of laminin for the purpose of modulating neural attachment and growth. The coating methods employed include
covalent immobilization on dextran-coated surfaces [Massia et al., 2004], covalent immobilization on amino-modiﬁed glass (Kam et al., 2002), self-assembling
peptide nanoﬁbers [Tysseling-Mattiace et al., 2008, Wu et al., 2006], copolymerization with conductive polymers [Cui et al., 2001, Stauﬀer and Cui, 2006], electrostatic layer-by-layer deposition [He et al., 2006], microcontact printing [James
et al., 2000, St. John et al., 1997], ﬁber templating within a hydrogel [Yu and
Shoichet, 2005], and covalent binding to silica sol-gel [Jedlicka et al., 2006,
2007a].
These studies present in vitro results showing that coatings containing whole
laminin (He and Bellamkonda, 2005), laminin sequences YIGSR [Cui et al.,
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2001, Yu and Shoichet, 2005] or IKVAV [Jedlicka et al., 2007a, Massia et al.,
2004, Yu and Shoichet, 2005] result in improved neuron and neuron-like cell
(PC12) growth. The incorporation of the laminin fragment RGD, however, resulted at best in a non-speciﬁc eﬀect on multiple cell types [Zhang et al., 2005]
and at worst a preferential adhesion aﬃnity for non neuronal cells [Kam et al.,
2002]. More recently, the immobilization of a neuron speciﬁc adhesion molecule,
L1, on a silicon substrate electrodes was investigated and showed improved neural adhesion in vitro [Azemi et al., 2008] and in vivo [Azemi et al., 2011].
Kam et al. have taken the converse approach, studying the eﬀects of peptide
sequences on astrocyte adhesion [Kam et al., 2002]. Their results showed that
YIGSR and IKVAV have no eﬀect on astrocyte growth and adhesion in vitro,
but that the Neural Cell Adhesion Molecule (NCAM) sequence KHIFSDDSSE
causes increased astrocyte growth compared to ﬁbroblasts. Since NCAM is
known to have an inhibitory eﬀect on astrocyte proliferation following injury
[Sporns et al., 1995]. Kam et al. argue that immobilizing the KHIFSDDSSE
sequence to a neural electrode could attenuate the intensity of the resulting
glial scar in vivo. The eﬀect of this NCAM-modiﬁed surface on neurons was not
investigated, and there was no in vivo follow up.
While these in vitro studies show potential for biomimetic coatings, in vivo
studies have yet to show an unambiguous improvement in the reactive tissue
response when such coatings are used. Cui et al. [2003] have shown that the incorporation of YIGSR in polypyrrole coatings result in more neuron survival at
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the electrode site compared to control sites. He et al. [2006] have demonstrated
that electrostatically deposited laminin results in a less intense glial scar. Neither of these studies, however, show a concrete and satisfactory improvement
of electrode performance over a long time scale, and much research remains to
be done in this ﬁeld.

2.3.4

Drug elution

A diﬀerent approach to neurointegrative coatings is to use drug elution to
attenuate the inﬂammatory response to the implanted electrode. Such additives include neuropeptides such as α-melanocyte-stimulating hormone (αMSH) and synthetic glucocorticoids such as methylprednisolone and dexamethasone [He and Bellamkonda, 2008, Li et al., 2005]. Peripheral injections
of dexamethasone starting at the day of injury and continuing for 6 days have
been shown to result in a profound attenuating eﬀect on both the initial and
sustained tissue responses [Spataro et al., 2005]. The systemic delivery of such
anti-inﬂammatory compounds risks signiﬁcant side eﬀects, however, leading to
research into drug elution techniques for the local delivery of these agents to the
injury site. Ravi Bellamkonda’s research group has demonstrated the feasibility of local anti-inﬂammatory drug delivery. Using a nitrocellulose-based coating for the sustained in vivo release of dexamethasone [Zhong and Bellamkonda,
2007] and α-MSH [Zhong and Bellamkonda, 2005] they showed a weakened tissue response over a four week period. Kim and Martin have demonstrated a
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successful system for in vitro dexamethasone release from an alginate hydrogel matrix [Kim and Martin, 2006]. Wadhwa et al. [2006] have implemented
a system for the electrochemically-controlled release of dexamethasone in vitro
from polypyrrole ﬁlms, while Abidian et al. [2006] have implemented a similar
system for dexamethasone release from PEDOT and polypyrrole. A limitation
of controlled drug release is that it is not sustainable over the long term, typically lasting days to weeks. To counter this limitation, He et al. [2007] immobilized α-MSH onto the silicon surface of neural electrodes resulting in an
anti-inﬂammatory surface that elicited a signiﬁcantly weaker tissue response.
Using a diﬀerent approach to mitigate the reactive tissue response, Winter et al. [2007] have implemented a system for the controlled release of nerve
growth factor (NGF) from a polyethylene glycol-polylactic acid (PEGPLA) hydrogel. This in vitro study showed that NGF-loaded hydrogel coatings on neural
microelectrodes can sustain the release of NGF for 1 week with little eﬀect on
the electrical properties of the electrodes a signiﬁcant positive eﬀect on the survival and neurite extension of PC-12 cells.
While there is an extensive body of literature describing the reactive brain
tissue response to implantable electrodes, there is no completely successful
treatment regime currently in place. Sheafs of published literature currently
show that any eﬃcacy displayed by a particular treatment only lasts for a month
at most. This places a huge obstacle to the further implementation of intracortical microelectrode-based neural prostheses. As shown by Szarowski et al.
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[2003], the extent of the glial scar depends greatly on the extent of the acute
damage, demonstrating the need to modulate the initial response, especially
edema and the attachment and activation of microglia.
One important factor aﬀecting the extent of the reactive tissue response,
demonstrated by Seymour and Kipke [2007] is electrode size. The many advantages of silicon-based microelectrodes, including ease of fabrication and reliable
large-scale production, make them indispensable in neuroprosthetic research
at this point, despite their non-optimal size. Neurointegrative coatings must
be designed in such a way that they do not exacerbate neuronal displacement,
yet have enough coverage to treat the entire device shank, rather than just the
electrode site.
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3. SOL-GEL THIN FILM COATINGS FOR IMPLANTABLE
INTRACORTICAL MICROELECTRODES
3.1

Introduction
The complexity underlying the RTR to implanted ICMs means that approaches

towards mitigating it will likely entail multiple modalities, including immobilized biomimetic biomolecules, locally released anti-inﬂammatories, and systemically delivered drugs. Current drug delivery platforms are dominated by
hydrogels [Kim and Martin, 2006, Winter et al., 2007], which, while well established, are large in scale in comparison to ICMs, and might exacerbate neuronal
displacement eﬀects. Some electrically conductive electrode coatings, such as
PEDOT and carbon nanotubes, are capable of drug loading and delivery [Abidian et al., 2006, 2007]. They are, however, typically deposited only on the electrode sites, and cover only a small fraction of the indwelling part of the device. While some success has been demonstrated with direct grafting of bioactive molecules onto the substrate of the ICM device shanks [Azemi et al., 2008,
2011], such approaches can require multiple steps and the use of complicated
chemical techniques.
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One promising approach to mitigating the reactive tissue response is to coat
the microelectrodes in a porous silica thin ﬁlm using the sol-gel method. The
sol-gel technique allows for single-pot synthesis at ambient conditions. Dip
coated thin ﬁlms of ultraporous silica exhibit a ﬂat surface morphology, with
pore size and surface features of <25 nm, and a thickness of approximately
100 nm [Jedlicka et al., 2006]. With the incorporation of short peptide chains
into the silane precursor, peptide-presenting sol-gel silica thin ﬁlms can be
made with precise control over density of the presented peptides [Jedlicka et al.,
2007a,b]. These peptide-presenting silica thin ﬁlms have been shown to be excellent substrates for neuronal growth [Jedlicka et al., 2006, 2007a]. In addition, sol-gel thin ﬁlms are a viable drug delivery platform, achievable through
the controlled release of drugs encapsulated within the porous ﬁlm [Radin and
Ducheyne, 2007, Radin et al., 2009]. This coating technique thus has the potential to combine biomimetic material modiﬁcation with localized drug delivery,
but it is necessary to ﬁrst establish the eﬀects of such sol-gel thin ﬁlms on the
electrical properties of the microelectrodes. The purpose of this study is to explore the feasibility of applying sol-gel silica thin ﬁlm coatings to silicon-based
microelectrodes. Determining this feasibility includes verifying the adhesion
of the coating to the probes, as well as ensuring that the coatings do not signiﬁcantly detriment the electrode’s electrical properties. This characterization
is an important step toward developing these coatings towards better in vivo
neurointegration of implantable ICMs.
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3.2

Materials and methods

3.2.1

Coating technique

Sol-gel silica thin ﬁlm were prepared as previously described in Jedlicka
et al. [2006]. Brieﬂy, the precursor sol was prepared by mixing 3.8 mL tetramethylorthosilicate (TMOS) (Sigma-Aldrich, St. Louis, MO) with 850 mL ddH2O,
and subsequently adding 0.55 mL of 0.04N HCl to catalyze hydrolysis. The precursor was then sonicated for approximately 15 min. The sonicated mixture was
ﬁltered using a 0.2mm Whatman syringe ﬁlter. A solution was then mixed consisting of 300µL of the ﬁltered TMOS mixture, 700 µL of sterile-ﬁltered, pH6.0,
0.2M phosphate buﬀer, and 100 µL of methanol. The thin ﬁlms were produced
by dip coating the shanks of six single-shank silicon substrate microelectrodes
(NeuroNexus Technologies, Ann Arbor, MI) at a constant rate of 35mm/s into
this ﬁnal solution. Each of the six electrodes evaluated in this study had 16
individual iridium sites with a site area of 703 µm2, for a total of 96 coated electrode sites. The ﬁlms were allowed to gel for approximately 1 minute in air at
room temperature, and then stored in phosphate buﬀer for use.

3.2.2

Evaluation of coating

The presence and evenness of the sol-gel silica thin ﬁlms on the electrodes
were evaluated by incorporating a ﬂuorescent label into the coating. This was
achieved by adding a saturating quantity of ﬂuorescein sodium salt to the phos-
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phate buﬀer before coating, resulting in a silica thin ﬁlm with uniform ﬂuorescent label throughout. An electrode was coated in non-ﬂuorescent sol-gel
as a control to ensure that the coating itself did not autoﬂuoresce. To ensure
that ﬂuorescence of the labeled probe was not due to surface adhesion of the
ﬂuorescein, coated and uncoated control probes were dipped in a ﬂuorescein
sodium salt solution identical to that used to coat the ﬂuorescent probe, except
that TMOS was replaced with an equal volume of phosphate buﬀer. Fluorescent images were obtained 1 hour after coating using a Leica DM-IRB ﬂuorescence microscope. Images of the ﬂuorescently labeled probes were collected at
a 525 nm wavelength emission using 490 nm excitation. Fluorescence in images of the coated electrodes with ﬂuorescein label was compared against the
control electrodes, which were not labeled. To evaluate stability of the coating,
an established phantom brain model was utilized [Chen et al., 2004]. A single
shank, acute Michigan electrode was coated in the ﬂuorescently labeled sol-gel
and imaged as described above. The probe was then inserted repeatedly into
the brain model and then imaged again. Stability was assessed by continued
ﬂuorescence following insertion in the phantom brain.

3.2.3

Electrical characterization

Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV)
measurements were collected using an Autolab potentiostat PGSTAT12 (EcoChemie, Utrecht, The Netherlands) with built in frequency analyzer (Brinkman,

30
Westbury, NY). A three electrode setup was utilized for in vitro experiments,
with the coated NeuroNexus acute, single-shank electrodes serving as the working electrode. A calomel electrode (Fisher Scientiﬁc,Waltham, MA)was used as
a reference electrode, and a platinum wire as the counter electrode. Measurements were performed in 1x PBS at room temperature. EIS and CV were preformed prior to and 1 day following application of the thin ﬁlm coatings. To perform EIS, a 25mV RMS sine wave was applied to electrode sites with frequencies
ranging logarithmically from 0.1 to 10 kHz. CV was performed by sweeping a
voltage linearly from-0.6 to +0.8V at a scanning rate of 1 V/s. Sites with broken
or poor connections, detected by having a maximum current in cyclic voltammograms below 1 nA, were excluded from the data set. The impedance data gathered from EIS were averaged across all sites. The impedances were separated
into resistive and reactive components, and were compared for the pre-coated
and post-coated probes at all measured frequencies. Changes in resistance, reactance, and impedance magnitude were evaluated using t-tests with p<0.05
indicating statistical signiﬁcance. Current values from cyclic voltammograms
were likewise averaged across all electrode sites. The charge carrying capacity
was calculated by integrating the cathodic current density curve generated by
the cyclic voltammogram and dividing by the sweep rate, and was compared
before and after coating.
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3.3

Results
Fluorescent imaging shows ﬂuorescence on the electrode coated with the la-

beled sol-gel but not on the control (Figure 3.1), indicating adherence of the
sol-gel ﬁlm to the electrode. The majority of the coating ﬂuoresced uniformly;
however, there were patches of increased ﬂuorescence, suggestive of local coating irregularities or clumps within a thin, even ﬁlm. Absence of ﬂuorescence
on the control probe demonstrates that the coating is not auto-ﬂuorescent, and
that the ﬂuorescence of the labeled probe is due to encapsulation within the
pores of the sol-gel ﬁlm, rather than adhesion on the ﬁlm’s external surface.
In addition, uncoated probes dipped in the ﬂuorescein solution displayed no
ﬂuorescence (data not shown), indicating that the ﬂuorescence seen in the experimental probe was not due to surface adhesion of the label directly onto the
probe surface. The stability of the coating on the probe was conﬁrmed through
continued ﬂorescence after inserting the probe into a phantom brain (data not
shown). The coating appeared unaltered after insertion into the model, demonstrating adherence of the coating to the probe given similar mechanical stresses
during surgical insertion.

The results of cyclic voltammetry show moderate changes in the voltammograms post-coating (Figure 3.2A), with larger current magnitudes observed for
all voltages along the sweep. Cathodic charge storage capacity post-coating ex-
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Fig. 3.1. Fluorescence microscopy conﬁrms the adherence of solgel coatings to microelectrodes. (A) Bright ﬁeld image of probes
to show their location. (B) Fluorescent micrograph of coated
probes. Left probe is unlabeled control, right probe is ﬂuorescently labeled. These images demonstrate that the silica solgels can be successfully applied to silicon-based microelectrodes.
Additionally, these images conﬁrm the ability to encapsulate
molecules in the TMOS precursor to facilitate biomolecule delivery to the implantation site. Reprinted from Pierce et al. [2009]
with permission.
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hibited a statistically signiﬁcant increase (p<0.001) compared to pre-coated values (Figure 3.2B).

Comparison of the resistance and reactance as a function of frequency reveals an increase in resistance and a decrease in reactance (Figure 3.3A).The
impedance magnitude pre and post coating demonstrates a decrease in impedance
after coating at all frequencies tested (Figure 3.3B). Nyquist plots of the electrochemical impedance spectroscopy data exhibit a shift in the impedance curve
towards increased resistance and decreased reactance, particularly at low frequencies (Fig. 4A). At low frequencies, both the resistive and reactive changes
are more pronounced, with the reactance dominating the total impedance. Comparing the impedances at the individual frequencies of 100 Hz, 1 kHz, and
10 kHz (Fig. 4B–D), the resistance increases signiﬁcantly across all frequencies
(p<0.001), whereas the reactance is signiﬁcantly decreased at 100 Hz (p<0.001),
becomes unchanged around 1 kHz (p=0.1156), and is signiﬁcantly increased at
10 kHz (p<0.001). The 100 Hz decrease is much larger in magnitude than the
10 kHz increase.

3.4

Discussion
A key consideration in coating an electrode is how the coating material af-

fects the electrical properties of the electrode. If a coating that aims to mitigate
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Fig. 3.2. (A) Representative cyclic voltammogram demonstrates
changes in hysteresis curve. Cyclic voltammograms pre- and
post-coating reveal an increase in current for each applied voltage of the sweep. This result indicates an increase in charge carrying capacity of the electrode site after application of the coating. (B) The average cathodic charge storage capacity (n = 92)
increases after coating for all experimental sites. The increase
in CV area is indicative of an increase in charge carrying capacity of the electrode following coating. Reprinted from Pierce et al.
[2009] with permission.
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Fig. 3.3. Plots generated from EIS performed before and after
coating show decreasing impedance losses with increasing frequency (n = 92). (A) Separated real and imaginary impedances
show a resistance increase and reactance decrease following coating, with the most pronounced eﬀects occurring at low frequency.
(B) The total impedance shows a general decrease with the most
pronounced eﬀect also occurring for low frequency. The total
impedance is dominated by the imaginary component. Reprinted
from Pierce et al. [2009] with permission.
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Fig. 3.4. (A) Representative Nyquist plot generated through
electrochemical impedance spectroscopy demonstrates changes
in impedance. Spectrograms obtained pre and post coating show
a moderate decrease in impedance magnitude for all frequencies.
(BŰD) Bar graphs showing average (n = 92) change in resistance
(R), reactance (X), and total impedance (Z) following coating for
(B) 100 Hz, (C) 1 kHz, and (D) 10 kHz. Resistance increases signiﬁcantly for all frequencies. Reactance and total impedance decrease signiﬁcantly at low frequencies, become unchanged near
physiological frequencies (i.e. 1 kHz), and become signiﬁcantly
higher at high frequencies. The reactance increase at high frequency is much smaller in magnitude than the decrease seen at
low frequency. Reprinted from Pierce et al. [2009] with permission.
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the RTR results in detrimental changes to the electrical properties of the electrode, this coating would be of little practical value. The cyclic voltammetry results from our study demonstrate an overall increase in charge carrying capacity for coated electrode sites. Increasing charge carrying capacity corresponds
to an increase in sensitivity for recording and allows for higher stimulation currents while minimizing voltage excursions [Wilks et al., 2009]. The increase in
charge carrying capacity may be due in part to the decrease in impedance; however, it should be noted that the charge carrying capacity changes may be overestimated since the original site area was used for its calculation, but the porous
coating likely increases the surface area across which charge transfer can occur.
The results of EIS show a general decrease in site impedance, with impedance
magnitude at the physiologically relevant frequency of 1 kHz being essentially
unchanged from a bare electrode. Decreases in site impedance will increase the
sensitivity of the electrodes, allowing for the detection of weaker signals across
larger distances. Such decreases in impedance following the application of a
non-conductive coating may be a result of increased capacitive charge transfer.
Similar eﬀects upon application of thin ﬁlm coatings have been noted in the
literature [Zhong and Bellamkonda, 2007]. The trends seen in the reactance
and total impedance support the idea that these impedance decreases are a result of increased capacitance caused by charge separation due to introduction
of the layer of thin, nonconductive silica. Because a capacitor’s impedance is
largest at small frequencies and decreases with increasing capacitance, an in-
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crease in capacitance of the electrode interface would account for the reactance
trend. Additionally, an increase in interfacial capacitance is consistent with the
observed increase in charge carrying capacity. The resistance increased for all
frequencies, as would be expected for an insulating layer. The electrical properties of sol-gel produced silica are highly dependent upon the material properties that result from the synthesis and treatment conditions of the ﬁlm. While
thick coatings of sol-gel silica sintered and densiﬁed by heat treatment substantially increase the total impedance [Hamdy et al., 2007, Pepe et al., 2006], high
porosity silica xerogels and aerogels have dielectric constants in the range of
2.1–3.95. Our results demonstrate that the dip-coated, ambient-dried thin ﬁlm
silica sol-gel coatings do not adversely aﬀect the electrical characteristics of the
implantable electrodes, and may in fact provide beneﬁcial electrical properties.
A major advantage of the sol-gel silica is the potential for simple biofunctionalization schemes. Together these features will allow the sol-gel silica coatings to
be used as a platform material for the mitigation of the RTR without causing
signiﬁcant detriment to the functionality of the probes.
The modest changes in the electrical properties of the probes should increase
signal-to-noise ratio and improve the quality of neural recordings. These effects will likely be small, and the primary advantage of the coating is its use
as a future platform for biochemical modulation of the electrode tissue interface. The impedance decreases observed in this study are much smaller than
those caused by ﬁlms or nanotube structures of poly(pyrrole) (PPy) or poly(3,4-
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ethylenedioxythiophene) (PEDOT), for which changes are one or more orders
of magnitude [Abidian et al., 2006, Wilks et al., 2009]. Likewise, the charge
carrying capacity increase is much more subtle than that caused by PPy or PEDOT. Although less advantageous electrically than conductive polymers, sol-gel
coatings provide a number of beneﬁcial properties. While polymer nanotubes
can deliver only small molecules, sol-gel materials can deliver a wide range of
biomolecules. In addition, the rate of release can be ﬁnely tuned by adjusting
the precursor silane to catalyst ratio [Avnir et al., 2006]. Another important
point of contrast between silica sol-gel coatings and conducting polymer coatings is the physical scale. While sol-gel coatings have a total thickness of approximately 100 nm, coatings of conductive polymer nanotubes have a thickness
ranging from 2 to 8.3 µm [Abidian and Martin, 2008].
The results of this study demonstrate the feasibility of applying silica sol-gel
materials to microelectrodes. The potential clinical applications that depend
on stable chronic recording from the cortex make the mitigation of the RTR a
crucial issue. Our ﬁnding that silica sol-gel thin ﬁlms can be coated onto ICMs
without adversely aﬀecting the electrical properties of the ICMs, combined with
potential application of silica-sol gels as a combinatorial drug releasing and
biomolecules presenting platform make silica thin ﬁlms an interesting research
avenue in the quest for alleviating chronic RTR.
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4. QUANTIFIABLE PROTEIN-ADSORPTION-CAUSED
CHANGES IN ELECTRODE IMPEDANCE ARE
PREVENTABLE USING DIP-COATED PEG
4.1

Introduction
Failure of intracortical microelectrodes (ICMs) associated with the forma-

tion of a dense glial scar and loss of neuronal density typically manifests as
increased impedance and decreased signal to noise ratios. In vivo impedance
monitoring is a common tool to assess the functionality of implanted ICMs, and
is used to infer the progression of the reactive tissue response to implanted
ICMs [Vetter et al., 2004, Williams et al., 1999, 2007]. Recent research showing that changes in electrical properties do not always perfectly correlate with
cellular responses implicates additional abiotic factors [Prasad and Sanchez,
2012, Prasad et al., 2012]. In vitro testing in 3D gel constructs revealed that
the diﬀerent glial cells have diﬀerent impedance proﬁles when adhered to the
surface of a microelectrode [Frampton et al., 2010]. While adsorbed proteins
have been implicated in the biological response(Leung et al., 2008), their eﬀects
on the electrical impedance of ICMs have not been described with impedance
spectroscopy. The prevalent electrical circuit model of the tissue electrode in-
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terface assumes that adsorbed proteins result in purely resistive impedance
changes [Otto et al., 2006, Williams et al., 2007] but there is not suﬃcient empirical veriﬁcation of this assumption.
Another important question in this regard is whether any detrimental changes
to the electrical characteristics of neural microelectrodes can be prevented using
simple and cost eﬀective approaches. For implantable devices in other biological
systems, protein-resistant treatments are commonplace [Bluestein et al., 2010,
Li and Henry, 2011, Salacinski et al., 2001]. One of the most common materials
used to enhance the biocompatibility of biomedical implants is polyethylene glycol (PEG). Due to its hydrophilic nature, it prevents the adsorption of proteins
by reducing access to the more hydrophobic surface onto which proteins prefer
to bind [Michel et al., 2005]. Typically PEG is chemically grafted onto a substrate and very reliably reduces protein adsorption [Muthusubramaniam et al.,
2011, Sharma et al., 2004a,b]. Current approaches in intracortical implant biocompatibility incorporate PEG as a scaﬀold for thick drug eluting hydrogels
[Lu et al., 2009, Rao et al., 2011, Winter et al., 2007], which might exacerbate
neuronal displacement.
This chapter will present an analysis of changes in ICM impedance following
immersion in a model protein solution mimicking in vivo brain protein concentration. Total impedance, as well as resistance and reactance, will be analyzed
at diﬀerent points across the frequency spectrum to elucidate the contribution
of adsorbed proteins to the impedance changes aﬀecting electrode performance.
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We will show that a dip-coated ﬁlm of high molecular weight PEG (HMWPEG)
prevents changes in impedance upon immersion in protein solution, and that in
vivo application of PEG in an acute setting reduces the magnitude of impedance
increase resulting from electrode insertion into tissue.

4.2

Materials and methods

4.2.1

Electrochemical measurements

Electrochemical measurements of 16-channel single shank Michigan electrode arrays (CNCT, Ann Arbor, MI) were made using an Autolab potentiostat
PG-STAT12 with a built-in frequency response analyzer (EcoChemie, Utrecht,
The Netherlands). A three-electrode cell conﬁguration was used with the microelectrode site functioning as the working electrode, a large-area Pt wire
functioning as the counter electrode, and an Accumet, gel-ﬁlled, KCl saturated
calomel electrode (Thermo Fischer Scientiﬁc, Fair Lawn, NJ) functioning as the
reference electrode. For each electrode array, Cyclic voltammetry (CV) was performed by sweeping the applied voltage from -0.6 to +0.8 V at a scanning rate
of 1 V/s to determine sites with broken or poor connections, designated as those
sites exhibiting a maximum current below 1 nA. These sites were discarded
from the analysis, thus yielding a total of 30 functional sites on 3 diﬀerent electrode arrays .
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Electrochemical impedance spectroscopy (EIS), using the PGSTAT12, was
used to measure the impedance of the electrode sites with the application of
16 sequentially applied sinusoidal waves at logarithmically spaced frequencies
ranging from 46 Hz to 10 kHz, with an amplitude of 25 mVRMS. For each electrode, impedance spectroscopy was performed in PBS following each of three
diﬀerent treatments: a) no treatment, b) immersion in a 10% solution of bovine
serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO) in PBS, the concentration of which was chosen to mimic protein concentration in rat cerebral cortex
[Banay-Schwartz et al., 1992], and c) immersion in a 20% solution of 4000MW
PEG (Alfa-Aesar, Ward Hill, MA), air-drying for one minute, then immersion in
BSA. An additional volume of 100 µL of PEG was further applied directly onto
the microelectrode shank as it was immersed in BSA to mimic a topical application. Electrodes were rinsed with deionized water and anodically cleaned
between the diﬀerent treatments using 10 second long DC pulses, as previously
described in Sommakia et al. [2009]. Impedance and phase spectra and Nyquist
plots were generated for all treatment groups. Comparisons of the resistance,
reactance and total impedance were done at 50 Hz, 100 Hz, 1 kHz, and 10 kHz.

4.2.2

Acute surgery

The laboratory animal protocol for this work was approved through the Purdue Animal Care and Use Committee (West Lafayette, IN, USA), and conforms
to the guidelines of the US National Institutes of Health. Two male Sprague
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Dawley rats (Harlan Laboratories, Indianapolis, IN) were used for this preliminary study. Each rat was anesthetized with 2% isoﬂuorane, then transferred to
a stereotactic frame and maintained with 0.5–1% isoﬂuorane delivered through
a nose cone. The head was shaved and swabbed with ethanol, and an eye lubricating ointment applied. Lidocaine was injected subcutaneously at multiple
positions in the head, and then a midline incision approximately 2cm long was
made along the cranium with a scalpel. The underlying pericranium was removed to expose the skull. A single burr hole was made with a dental drill
towards the back of the head, slightly anterior to the ears, and a stainless steel
bone screw with attached to a segment of platinum wire was threaded into it to
serve as a counter electrode. Bilateral craniotomies about 2.5 mm in diameter
were made with a dental drill, approximately 2.5 mm anterior to Bregma and 2
mm lateral to the midline. For each craniotomy, a slit was made in the dura using surgical microscissors. One craniotomy serving as control was wetted with
0.9% sterile saline before electrode insertion, while the other craniotomy was
wetted with 20% w/v solution of 4000MW PEG prior to electrode insertion. An
acute Michigan probe was used for this experiment, with its 1 kHz impedance
in PBS measured immediately before insertion. The control craniotomy was
done ﬁrst, with the electrode connected to Autolab potentiostat. The electrode
was held in a magnet-stabilized micromanipulator, and manually inserted into
the cortex. Five minutes after insertion, EIS was measured in a two-electrode
setup. The electrode was then removed, rinsed with MilliQ water, and cleaned
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by applying a DC bias of 1.5 V for 10 seconds as described in Sommakia et al.
[2009] and Chapter 5. After verifying the return of the 1 kHz impedance to
baseline, the electrode was immersed in a 20% solution of 4000MW PEG in
MilliQ water for 1 minute and allowed to dry for 2 minutes. The electrode was
then replaced in the micromanipulator and inserted into the cortex in the other
craniotomy wetted with PEG, and EIS was performed again.

4.2.3

Statistical analysis

Statistical analysis was done using the SAS 9.3 statistical package (SAS Institute, Cary, NC). A general linear model (GLM) procedure was used to perform
a one way ANOVA with block to remove variations between the diﬀerent electrodes by treating electrodes as a statistical block. Tukey post-hoc tests were
used to identify statistically signiﬁcant diﬀerences between the groups at a signiﬁcance level of α<0.05. Plots were generated using MATLAB (The MathWorks
Inc., Natick, MA).

4.3

Results

4.3.1

Analysis of impedance changes with model protein solution and
PEG in vitro

Figure 4.1(a) shows the magnitude spectrum for electrodes dipped into BSA
without pretreatment with PEG is higher than the magnitude spectrum for un-
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coated controls for all frequencies, indicating an overall increase in impedance.
In contrast, the magnitude spectrum for electrodes treated with PEG prior to
BSA immersion shows more congruence with the magnitude spectrum of the
control. Figure 4.1(b) shows the phase spectrum for non-PEG treated electrodes
immersed in BSA exhibits lower phase angles at the lower end of the frequency
spectrum, and the diﬀerence is most pronounced in the middle of the spectrum
between 200–500 Hz. For electrodes pretreated with PEG prior to BSA immersion, the phase angle is also lower than the controls, but higher than the
non-PEG electrodes, at the low frequency end of the spectrum. At higher frequencies, the phase angle of non-PEG electrodes approaches that of the controls,
whereas the PEG treated electrodes exhibit a reduced phased angle at frequencies higher than approximately 2 kHz.

Figure 4.2 shows the Nyquist plots for the diﬀerent treatments. The Nyquist
plot for electrodes not treated with PEG prior to BSA immersion appears shifted
up and the right compared to the controls, indicating both increased resistance
and reactance, with the most pronounced divergence occurring toward the middle of the plot. In contrast, the plot for electrodes pretreated with PEG shows
more congruence with the control in the middle of the plot and slight divergence
at the lower end of the plot, corresponding to the higher frequencies.
Figure 4.3 shows changes in the real component of the impedance, i.e. resistance, relative to the control at four frequency values across the spectrum.
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Fig. 4.1. (a) Total impedance magnitude spectrum for electrodes
not pretreated with PEG before BSA application is higher than
both the control and PEG treated electrodes. (b) Phase angle
spectrum for electrodes not pretreated with PEG prior to BSA
application shows a lower phase angle for lower and intermediate
frequencies compared to the control, while the phase angle spectrum for electrodes pretreated with PEG exhibits smaller phase
angles across all frequencies.
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Fig. 4.2. Nyquist plot for electrodes pretreated with PEG before
BSA application is close to the control plot, with a slight shift to
the left at lower frequencies, indicating a decrease in resistance.
Nyquist plot for electrodes not pretreated with PEG before BSA
shows a shift up and to the right, indicating increases in both
resistance and reactance.

Electrodes immersed in BSA without PEG pretreatment exhibited highly statistically signiﬁcant increases in the resistance compared to the uncoated control
at examined frequencies. The highest impedance increase relative to control
was in the middle of the frequency spectrum, speciﬁcally at 1 kHz, with a 30.7%
increase in resistance. At 50Hz, the increase in resistance in resistance for the
BSA coated electrodes without PEG pretreatment was 14.5%, at 100Hz, the resistance increase was 23.9%, and 10 kHz, the resistance increase was 17%. The
electrodes pretreated with PEG prior to BSA immersion, on the other hand, did
not exhibit any signiﬁcant diﬀerences in resistance compared to the uncoated

49

Relative Resistance( % of PBS control)

controls at all examined frequencies.

***
130

BSA, No PEG
BSA, PEG
Control

***
120

***

*

110

100

50 Hz

100 Hz

1 kHz

10 kHz

Fig. 4.3. Resistance: electrodes coated with BSA without PEG
pretreatment exhibited considerable and statistically signiﬁcant
increases in resistance (real impedance) compared to uncoated
controls at all frequency values studied. In contrast, electrodes
treated with PEG prior to BSA application did not exhibit any
signiﬁcant increases in resistance compared to the control at all
studied frequencies, and were all signiﬁcantly lower compared to
BSA coated electrodes. Control plot shown slightly oﬀset to the
left for clarity. Error bars represent the standard error of the
means.

Figure 4.4 shows changes in the imaginary component of the impedance,
i.e. reactance, relative to the control at four frequency values. For electrodes
not pretreated with PEG prior to immersion in BSA, no signiﬁcant increase in
reactance was observed at 50 Hz or 100 Hz, while increases of 4%, 12% and
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15% were observed at 100 Hz, 1 kHz and 10 kHz, respectively. In contrast,
electrodes pretreated with PEG prior to immersion in BSA exhibited modest
decreases in the reactance relative to control at all frequencies (-6.3% at 50Hz,

Relative Reactance( % of PBS control)

-6.3% at 100Hz, -4.2% at 1 kHz, and -4.8% at 10 kHz).
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Fig. 4.4. Reactance: for BSA coated electrodes, no change in reactance (imaginary impedance) was observed compared to uncoated control at 50Hz, whereas increases in reactance were observed at higher frequencies. PEG coated electrodes exhibited
slight decreases in reactance compared to uncoated controls at
frequencies greater than 50Hz. Control plot shown slightly oﬀset to the left for clarity. Error bars represent the standard error
of the means.

Figure 4.5 shows the changes in total impedance relative to the control at
four frequency values. For electrodes not pretreated with PEG prior to BSA im-
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mersion, no signiﬁcant diﬀerence in total impedance was observed at 50Hz, but
progressive increases in the impedance were observed at the higher frequencies
(4.5% at 100hz, 13.5% at 1 kHz, 15.3% at 10 kHz). For electrodes pretreated
with PEG prior to BSA immersion, modest decreases in total impedance were
observed at the lower frequencies (-5.8% at 50Hz, -5.6% at 100 Hz, -3.9% at
1 kHz), while no signiﬁcant diﬀerence in the total impedance compared to the

Relative Total Impedance( % of PBS control)

control was observed 10 kHz.
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Fig. 4.5. Total Impedance: for BSA coated electrodes, total
impedance exhibited statistically signiﬁcant increases compared
to uncoated controls except at 50Hz. For electrodes treated with
PEG prior to application in BSA, smaller but statistically signiﬁcant decreases in total impedance were observed except at
10 kHz. Control plot shown slightly oﬀset to the left for clarity.
Error bars represent the standard error of the means.

52
4.3.2

Preliminary analysis of impedance changes with and without
PEG in vivo

Figure 4.6 shows the percent increase of the real component of the impedance,
i.e. resistance, between the in vitro baseline and the in vivo measurement at
four frequency values across the spectrum. In both cases of PEG treatment or
non-treatment, the resistance increased signiﬁcantly when measured in vivo
compared to the in vitro baseline. Insertion into the cortex without PEG treatment, however, resulted in a larger increase from baseline compared to insertion with PEG treatment. The increases compared to baseline are presented in
table 4.1.

Table 4.1
Increase in resistance from baseline observed in vivo for No PEG
vs. PEG treatment at 4 frequencies (mean ± standard error).

No PEG
PEG

50 Hz

100 Hz

1 kHz

10 kHz

69.1±4.6%

112.2±5.9%

218.7±11%

305±15.8%

49±4.6%

56.6±5.9%

142.5±11%

215.2±15.8%

p=0.0033

p<0.0001

p<0.0001

p<0.0001

Figure 4.7 shows the percent increase of the imaginary component of the
impedance, i.e. reactance, between the in vitro baseline and the in vivo measurement at four frequency values across the spectrum. In both cases of PEG
treatment or none-treatment, the reactance increased signiﬁcantly when mea-
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Fig. 4.6. In vivo increase in resistance from baseline.

sured in vivo compared to the in vitro baseline. Insertion into the cortex without
PEG treatment, however, resulted in a larger increase from baseline compared
to insertion with PEG treatment. The magnitudes of the increases in reactance
were smaller than those for the resistance. The increases compared to baseline
are presented in table 4.2.

Figure 4.8 shows the percent increase of the total impedance between the
in vitro baseline and the in vivo measurement at four frequency values across
the spectrum. In both cases of PEG treatment or none-treatment, the total
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Table 4.2
Increase in reactance from baseline observed in vivo for No PEG
vs. PEG treatment at 4 frequencies (mean ± standard error).
50 Hz

100 Hz

1 kHz

10 kHz

No PEG

49.7±2%

53.7±2.7%

75.7±3.1%

157±7.3%

PEG

30.4±2%

32.2±2.7%

42.2±3.1%

91.8±7.3%

p=0.0033

p<0.0001

p<0.0001

p<0.0001
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Fig. 4.7. In vivo increase in reactance from baseline.

impedance increased signiﬁcantly when measured in vivo compared to the in
vitro baseline. Insertion into the cortex without PEG treatment, however, resulted in a larger increase from baseline compared to insertion with PEG treatment. The increases compared to baseline are presented in table 4.2.
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Table 4.3
Increase in total impedance from baseline in vivo for No PEG vs.
PEG treatment at 4 frequencies (mean ± standard error).
50 Hz

100 Hz

1 kHz

10 kHz

No PEG

52.3±2.1%

58.7±2.9%

98.9±4%

222.5±11%

PEG

31.5±2.1%

34.2±2.9%

57.5±4%

154.2±11%

p = 0.0033

p < 0.0001

p < 0.0001

p < 0.0001

Total Impedance
250

Percent increase from baseline (%)

No PEG
PEG
200

150

100

50

0

50 Hz

100 Hz

1 kHz

10 kHz

Fig. 4.8. In vivo increase in total impedance from baseline.

4.4

Discussion

4.4.1

Rationale

The in vivo reactive tissue response is an aggregate of ampliﬁed biological
processes that begin with device insertion and accompanying trauma. The in-
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dwelling implant acts as a nucleation site/sink for various proinﬂammatory proteins, as well as substrate for cell attachment [Leung et al., 2008]. A quantiﬁcation of the eﬀects of immediate protein adhesion onto neural electrodes on
the electrical properties of the microelectrodes does not exist in the literature.
Countering the eﬀects of protein adsorption onto neural microelectrodes is important inasmuch as it actually improves device performance, particularly as
inferred by its electrical properties. Current eﬀorts in combating the reactive
tissue response focus on targeting and quantifying the cellular component of
the reactive tissue response. A potential alternative might be to quantify and
target molecular and extracellular components.

4.4.2

Explanation of results

As seen from the impedance and phase angle spectra and the Nyquist plots,
the quantitative eﬀects on electrode impedance are not easily discernible by
examining log-plot Bode and Nyquist plots. We therefore examined the relative resistance, reactance, and total impedance at various points across the
frequency spectrum to better understand how protein adsorption aﬀects the
electrical properties of neural microelectrodes, and how attempts to mitigate
protein adsorption might aﬀect electrode performance.
Our ﬁrst ﬁnding was that readily apparent and signiﬁcant increases in resistance at all examined frequencies occur immediately upon exposure to a pro-
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tein solution at a concentration mimicking in vivo concentrations. Furthermore, signiﬁcant increases in the reactance are observed at higher frequencies,
including the physiologically relevant 1 kHz. The aggregate impedance eﬀect
is that of a signiﬁcant increase at frequencies higher than 50Hz. These observed in vitro changes in impedance might not exactly match in vivo changes,
given the diﬀerence in protein composition in the brain, and the presence of
additional biomolecules with widely varying degrees of hydrophobicity, such as
lipids and polysaccharides [Margolis and Margolis, 1974, Norton et al., 1975,
O’Brien and Sampson, 1965, Pease, 1966]. This ﬁnding of changes in both resistive and capacitive component following protein adsorption challenges current assumptions inherent in prevalent electrical circuit models of the device
tissue interface. Such models typically assume that protein adsorption causes
purely resistive changes in impedance [Otto et al., 2006, Williams et al., 2007].
We demonstrate that the exposure of microelectrodes to a protein solution results in both resistive and capacitive changes in impedance, rather than purely
resistive changes. These ﬁndings suggest a need for the reexamination of assumptions upon which prevalent electrical circuit models for the tissue electrode
interface are built.
Our study further demonstrates that treating electrodes with a PEG ﬁlm
via dip coating prior to immersion in a protein solution negates these increases
in impedances at physiologically relevant frequencies. That the reactance exhibits slight decreases for electrodes pretreated with PEG supports our work-
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ing hypothesis that the PEG ﬁlm forms a hydrated layer close to the electrode
surface that prevents proteins from accessing the surface of the electrode, while
simultaneously avoiding detrimental eﬀects on charge transfer at the electrodeelectrolyte layer. As expected, electrode insertion into the brain results in a
considerable increase in impedance, both resistive and capacitive, as predicted
by electrode tissue interface models [Otto et al., 2006, Williams et al., 2007].
The addition of an aqueous solution of HMWPEG by dip-coating onto the microelectrode and directly into the craniotomy resulted in a reduction in the magnitude of the increase from baseline. Because cellular responses in the brain
are not observed until several hours post implantation [Kozai et al., 2012b],
this suggests that a considerable portion of the immediate impedance increase
comes from biomolecules with hydrophobic properties that come into contact
with the electrode surface and hinder charge transfer. The presence of free
HMWPEG entering the brain simultaneously with the electrode appears to confer some degree of protection from the eﬀects of aforementioned biomolecules.
While grafted microscale antifouling coatings that prevent cellular adhesion
in vitro do not result in signiﬁcant improvement to the cellular composition of
the chronic electrode tissue interface [Gutowski et al., 2013], the eﬀects of such
coatings on the electrical behavior of functional electrodes has not been tested.
Applying higher molecular weight PEG in solution has been shown to improve
cellular and behavioral recovery in traumatic brain injury [Koob and Borgens,
2006, Koob et al., 2005, 2008], due to its hydrophilicity achieving membrane
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sealing eﬀects. It is possible that this property of HMWPEG can be similarly effective in disrupting deposition of proteins and other molecules at the electrode
vicinity. It has been suggested that cellular, speciﬁcally microglial, responses
do not consistently correlate to electrode performance [Prasad et al., 2012]. Our
ﬁndings, in conjunction to these observations from the literature, suggest the
importance of future studies to correlate in vivo electrode performance with
molecular and extracellular components of the reactive tissue response.
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5. DIRECT CURRENT BIASING FOR THE RESTORATION
OF SITE IMPEDANCE OF NEURAL MICROELECTRODES
5.1

Introduction
Acute experiments using penetrating silicon-shank intracortical microelec-

trodes (ICMs) have been successfully used to study electrophysiology in the
central nervous system [Crea et al., 2009, Hoa et al., 2008, McConnell et al.,
2007, Niu et al., 2013, Snyder et al., 2008]. The major advantage of penetrating
ICMs is the high speciﬁcity conferred by their small size scale and their ability
to reach physiologically relevant neuron populations inside the cortex [Anderson et al., 1989, Drake et al., 1988]. These properties simultaneously constitute a disadvantage because the insertion procedure causes localized injury to
neural tissue and the blood brain barrier, including cell lysis and blood vessel
permeabilization [Saxena et al., 2013]. This injury results in the extravasation of blood borne protein and cells and the accumulation of a diverse range
of molecules on the electrode surface [Fawcett and Asher, 1999, He and Bellamkonda, 2008, Leung et al., 2008]. The smaller size of the electrically active
sites on neural microelectrodes makes them geometrically more susceptible to
accumulation of cellular and extracellular biomolecules. This eﬀect is also true
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when exposing such electrodes in vitro to model protein solutions and phantom brains for the sake of various tests. This accumulation of proteins, cell
debris, and other biomolecules can result in an increase in the impedance of
the electrode site. Increases in impedance can be detrimental to in vivo recording sensitivity and to electrode assessment in other in vitro tests [Vetter et al.,
2004, Williams et al., 2007].
Protein removal from surfaces is a time and labor intensive process, most
commonly involving various surfactants and electrophoresis techniques [Green
et al., 2001, Magnani et al., 2004, Vinaraphong et al., 1995]. Ultrasonic cavitation (sonication) is another common alternative which functions by creating
oscillating nanobubbles at the surface. These cavitations exert drag and shear
forces that remove adsorbed proteins [Maisonhaute et al., 2002a,b]. The brittle
mechanics of silicon [Stieglitz et al., 2000], however, limit the use of ultrasonic
cavitation. Piranha solution etching is the most robust method of removing organic residues [Verhaverbeke and Christenson, 2001], but Piranha solution is a
volatile and potentially explosive material, and cannot be safely used to quickly
clean electrodes within a surgical setting. NeuroNexus, a prominent manufacturer of silicon-shank microelectrodes, recommends soaking electrodes in a
multipurpose contact lens cleaner for a few hours. This recommendation restricts the reuse of an acute electrode in same day experiments, and, as we
will demonstrate in this paper, soaking microelectrodes in contact lens solution
results in substantial increases in electrode site impedance.
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One approach that has been shown to successfully, albeit temporarily, restore recording capabilities to encapsulated chronic microelectrodes is DC biasing at voltages outside the water window [Johnson et al., 2005, Otto et al., 2006].
Application of DC voltages above 0.8 V in an electrochemical cell results in the
electrolysis of water and the production of hydrogen gas [Holladay et al., 2009].
Similar approaches have been used to remove metal oxide layers by holding a
constant potential at a relatively voltage high in a strong acid solution [Robblee
et al., 1983]. Similarly, we posit that DC voltages applied to electrode sites of
an iridium microelectrode in an electrochemical cell with an aqueous electrolyte
will result in the decomposition of water at the electrode-electrolyte surface and
the production of hydrogen gas bubbles. We hypothesize that these bubbles
would exert forces on adsorbed biomolecules somewhat similar to those forces
exerted by nanobubbles in sonication, with similar results. In this paper we
demonstrate the utility of using DC anodic cleaning to restore the impedance
of silicon microelectrodes following exposure to various biomolecules. We will
show that applying a DC voltage to an electrode for as little as 2 seconds results
in a signiﬁcant and considerable decrease in impedance, and that pulses of over
10 seconds are suﬃcient to achieve a stable impedance value. We demonstrate
the use of this technique to clean electrodes placed in protein solution, phantom
agar brain, and rat brain tissue.
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5.2

Methods

5.2.1

Electrochemical measurement and DC biasing

Electrochemical measurements of acute 16-channel single shank Michigan
electrode arrays (NeuroNexus Inc., Ann Arbor, MI) were made using an Autolab potentiostat PG-STAT12 with a built-in frequency response analyzer (EcoChemie, Utrecht, The Netherlands). Both two- and three-electrode cell conﬁgurations were used with the microelectrode site functioning as the working
electrode and a large-area Pt wire functioned as the counter electrode. For
the three-electrode conﬁguration, an Accumet, gel-ﬁlled, KCl saturated calomel
electrode (Thermo Fischer Scientiﬁc, Fair Lawn, NJ) functioned as the reference electrode. Measurements were performed in 1x PBS at room temperature. To determine sites with broken or poor connection, cyclic voltammetry
(CV) was performed by sweeping the applied voltage from -0.6 to +0.8 V at a
scanning rate of 1 V/sec . Sites exhibiting a maximum current below 1 nA were
discarded from the analysis. Electrochemical impedance spectroscopy (EIS), using the PGSTAT12, was used to measure the impedance of the electrode sites
with the application of 16 sequentially applied sinusoidal waves at logarithmically spaced frequencies ranging from 46 Hz to 10 kHz, with an amplitude of
25 mV RMS. For the DC biasing, the PG-STAT12 was instructed to apply a
constant voltage of 1.5 V for a set duration.
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5.2.2

DC duration study

To study the eﬀect of DC biasing duration, electrodes were placed with the
silicon shank in Equate brand multipurpose contact solution (Walmart, Bentonville, AR) overnight, then removed and rinsed with MilliQ water, as per
instruction from the NeuronexusNeuroNexus website. Electrodes were then
placed in three-electrode cell described above and EIS was performed to obtain
the baseline impedance. A 1.5 V DC voltage was applied for 2 seconds, and
the impedance was measured again. This procedure of paired consecutive DC
biasing and EIS was repeated eight times, for a total DC biasing time of 16
seconds.

5.2.3

In Vitro biomolecule models

To demonstrate the eﬃcacy of DC biasing at restoring electrode impedance
following exposure to biomolecules, two models were employed. Model protein solution was a 10% weight/volume bovine serum albumin (Sigma-Aldrich,
St. Louis, MO) in MilliQ water, prepared as described previously [Sommakia
et al., 2009]. Phantom brains were prepared by mixing 1% agar (Sigma Aldrich,
St. Louis, MO) in 1x PBS on a heated magnetic stirrer until well dissolved,
and allowed to set for 2 hours at room temperature then overnight at 4 degrees. For each model, EIS measurements were performed to measure baseline
impedance. The electrode was then aﬃxed to a manipulator and immersed in
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the BSA solution or inserted in the phantom brain. Electrodes were held in
BSA for 5 minutes and in agar for 15 minutes. Electrodes were then removed
and placed back into the three-electrode cell. EIS was performed to measure
impedance, and then DC biasing at 1.5 V was performed for 15 seconds, and
EIS performed again. Eﬃcacy of DC biasing method was evaluated by examining the 1 kHz impedance, which is a typical metric for evaluating microelectrodes [Cogan, 2008].

5.2.4

DC biasing following acute in vivo implant

To demonstrate the eﬃcacy of DC biasing at restoring electrode impedance
during acute surgeries, DC biasing was performed during the course of acute
surgeries. The laboratory animal protocol for this work was approved through
the Purdue Animal Care and Use Committee (West Lafayette, IN, USA), and
conforms to the guidelines of the US National Institutes of Health. Brieﬂy, male
Sprague Dawley rats (Harlan Laboratories, Indianapolis, IN) undergoing acute
surgeries are anesthetized with 2% isoﬂuorane and placed into a stereotactic
frame. A subcutaneous injection of 0.5 ml of Lidocaine was administered, and
then a midline incision was made along the cranium with a scalpel. A 2 mm
diameter craniotomy was made with a dental drill, approximately 2.5 mm anterior to Bregma and 2 mm lateral to the midline. A slit in the dura was made
using microscissors, and the electrode inserted into the brain with a magnetstabilized micromanipulator. Once the experiment was concluded, the electrode
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was withdrawn from the brain and rinsed in MilliQ water. EIS was performed
in a two-electrode conﬁguration at the surgical site, after which DC biasing was
applied at 1.5 V for 15 seconds, and the EIS performed again.

5.2.5

Data Analysis

Experiments were run in triplicate except for the in vivo acute surgery, which
was performed in duplicate. EIS data was extracted using a custom MATLAB
(MathWorks, Natick, MA) function. Statistical analysis was performed using
the SAS statistical package (SAS Institute, Cary, NC). A generalized linear
model procedure was used to perform a one-way ANOVA with blocking to remove the eﬀect of variations between electrodes and extract the least square
means of the treatments. Post-hoc Tukey tests were performed to determine the
pairwise diﬀerences between the treatments to a signiﬁcance level of α = 0.05.
Graphs were plotted using MATLAB.

5.3

Results

5.3.1

Effects of Duration of DC biasing

Figure 5.1 shows the eﬀect of the duration of DC biasing at 1.5 V on electrodes that have been placed in contact solution overnight. Figure 5.1(a) shows
the eﬀect of DC biasing on the Total impedance magnitude at 1 kHz. Without any DC biasing, these electrodes exhibit an average 1 kHz impedance of
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3456.8 kΩ. Applying a 1.5 V DC bias for 2 seconds reduces the average 1 kHz
impedance to 1181.2 kΩ (p<0.0001, compared to uncleaned), a decrease of 65%.
A total of 4 seconds of cumulative DC biasing reduces the average 1 kHz impedance to 901.05 kΩ (p=0.0048 compared to 2 sec), a total decrease of 74% from
the impedance of uncleaned electrodes. Additional DC biasing for durations
longer than 4 seconds slightly reduces the 1 kHz impedance, with no statistically signiﬁcant diﬀerence observed until 12 seconds of cumulative DC biasing,
where the 1 kHz impedance is 661.2 kΩ (p=0.031). The observed mean 1 kHz
impedance over time can be ﬁtted to an exponential decay function (Rsquare
value).
Analyzing the reactance and resistance separately as shown in Figure 5.1(b)
reveals that the reactance follows an extremely similar pattern to the total
impedance at 1 kHz. Uncleaned electrodes with a 1 kHz reactance of 3211 kΩ
drops down to 1134.2 kΩ with 2 sec of DC biasing at 1.5 V, a decrease of 64%
(p<0.0001). Cumulative DC biasing for 4 seconds reduces the reactance to
865.9 kΩ, a decrease of 73% from the uncleaned electrodes. Additional DC biasing slightly reduces the reactance, but a statistically signiﬁcant diﬀerence does
not occur again until 12 seconds of cumulative DC cleaning, where the reactance is observed to be 636 kΩ. The resistance at 1 kHz changes in a slightly
diﬀerent manner. DC biasing for 2 seconds results in a decrease from 1238.7 kΩ
to 327.5 kΩ, representing a decrease of 73%. Unlike the reactance, DC biasing
longer than 2 seconds did not result in signiﬁcant decreases in the resistance.
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Fig. 5.1. Eﬀects of progressively increasing durations of DC biasing on total impedance (a), and resistance and reactance (b)
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Fig. 5.2. Nyquist plot of electrodes immersed overnight in multipurpose contact solution before DC biasing and after 10 seconds
of DC biasing.

5.3.2

Effects of DC biasing on the components of the impedance

The Nyquist plot shown in Figure 5.2 shows a comparison between the impedance of electrodes placed overnight in multipurpose contact solution before
and after 10 seconds of DC biasing. A shift to the left and up is observed after
cleaning, indicating a decrease in both the resistance and the reactance at all
frequencies. The slope of the line approximately doubles after cleaning, indicating that changes to the resistive component of the impedance are stronger
than the capacitive components.
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5.3.3

Effects of DC biasing following model biomolecule adsorption

Figure 5.3(a) shows that a set of electrodes immersed in BSA experienced
a statistically signiﬁcant increase of 17% (from Z=491.7 ± 4.9 kΩ to Z=573.13
± 4.54 kΩ) in the 1 kHz impedance compared to baseline (p<0.0001). After
DC biasing for 15 seconds at 1.5 V, the 1 kHz impedance returned to a value
statistically identical to the baseline impedance (Z=481.9 ± 4.54 kΩ).
Figure 5.3(b) shows that a diﬀerent set of electrodes inserted into an agar
phantom brain experience a statistically signiﬁcant increase of 20.2% (from Z=
340.16 ± 5.5 to Z= 409.27 ± 5.58 kΩ) compared to baseline (p<0.0001). After
DC biasing at 1.5 V for 15 seconds, the 1 kHz impedance returned to a value
indistinguishable from baseline impedance (Z=339.29 ± 5.77 kΩ).

5.3.4

Effects of DC biasing following in vivo exposure to brain tissue

Figure 5.4 shows that electrodes inserted into rat cortex during an acute
surgery experience a statistically signiﬁcant increase of 33% (from Z=480.59 ±
12.15 to 639.61 ± 12.15 kΩ) in the 1 kHz impedance compared to baseline. After DC biasing for 15 seconds at 1.5 V, the 1 kHz impedance returned to a value
statistically identical to the baseline (Z=470 ± 12.15 kΩ).

71

Impedance at 1 kHz relative to baseline (%)

120

*

110

100

baseline

BSA

DC cleaned

Impedance at 1 kHz relative to baseline (%)

(a) Eﬀects of DC biasing for 15 seconds on electrodes immersed in a
10% w/v BSA solution on the 1 kHz impedance, showing a reliable
return to baseline

*
120

110

100

baseline

Agar

DC cleaned

(b) Eﬀects of DC biasing for 15 seconds on electrodes inserted into
agar phantom brain on the 1 kHz impedance, showing a reliable
return to baseline.
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Fig. 5.4. Eﬀects of DC biasing for 15 seconds on the 1 kHz
impedance of electrodes acutely implanted into rat cortex, showing a reliable return to baseline.
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5.4

Discussion
The use of neural microelectrodes with lower impedance is a common ap-

proach to improving recording sensitivity [Keefer et al., 2008, Ludwig et al.,
2011]. While tissue and extracellular components are the major culprits in degrading recording quality for chronic electrodes, the time scale in most acute
experiments is not long enough for these tissue responses to develop [Kozai
et al., 2012b]. In such experiments, increases in the electrode impedance will
be the result of adsorbed protein and other biomolecules from brain tissue. Most
common cleaning procedures are time intensive, and cannot practically be performed within the conﬁnes of an acute experiment. In this chapter we described
an alternative cleaning method using DC biasing to restore electrode impedance
following exposure to a variety of biomolecules and brain tissue. Concerns about
altering the chemical composition of the electrode are not realized with DC biasing at 1.5 for durations of less than 20 seconds, as observed by the 1 kHz
impedance approaching asymptotic values. Typically, oxidation of iridium to
form activated iridium oxide (AIROF) is achieved by repetitive voltage cycling
in sulfuric acid [Burke and Whelan, 1984, Robblee et al., 1983, Zerbino et al.,
1978], so it is unlikely that activated iridium oxide layers would form on electrodes cleaned by DC biasing in PBS. We have not investigated the eﬀect of
holding DC bias on a microelectrode for durations longer than 20 seconds, since
durations under 20 seconds appear to be suﬃcient to return electrodes exposed
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to biological solutions to baseline values. The drawback of this method is that
the cleaning eﬀect of the DC biasing is likely to be conﬁned to the surface of the
electrode site, and would not be useful to remove adsorbed molecules elsewhere
on the electrode shank. We propose that this method is a useful approach to
cleaning electrodes during acute experiments with multiple insertions for the
same electrode. It could also be used as an adjunct cleaning step for chronic
electrodes pre-implantation, either prior to or following sterilization.
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6. CELLULAR RESPONSES TO MICROSCALE FOREIGN
BODIES DIP-COATED WITH LPS AND PEG
6.1

Introduction
The biological pathways governing the progression of the RTR to ICMs are

not well characterized. Dural and blood vessel damage appears to be a major factor contributing to the RTR [Saxena et al., 2013]. This RTR has been
shown to be non-uniform and depth related [Woolley et al., 2013], with stronger
scarring closer to the surface of the brain. Recent work has shown that transdural implants elicit a much higher response that implants dwelling completely
within the brain [Markwardt et al., 2013]. These ﬁndings collectively suggest
that the introduction of dural ﬁbroblasts, blood borne cells, and proteins into
the brain activates inﬂammatory pathways, and that this activation is strongest
at the site of injury to these structures. Potential mechanisms include accumulation of reactive oxygen species and activation of toll-like receptor 4 (TL4)
[Potter et al., 2013, Ravikumar et al., 2013]. The complexity underlying in vivo
conditions and obscuring biological mechanisms can be somewhat controlled by
using in vitro cell culture models. The most widely used model was described
by Polikov et al. [2006, 2009] using microscale foreign bodies in primary mixed

76
neural cultures. This model has been widely applied to test biocompatibility
of various materials as neural interfaces [Achyuta et al., 2010, Ereifej et al.,
2013, Tien et al., 2013]. While this model relies on modifying culture media
to achieve a globally elevated activation state, we posit that the model can be
slightly modiﬁed by dip coating in lipopolysaccharide (LPS) to simulate an inﬂammatory microenvironment localized around the foreign body placed in the
cell cultures. LPS is a known upregulator of microglial activation through TL4
binding [Lehnardt et al., 2003, Tzeng et al., 2005], and as such is an attractive option for modifying the Polikov model to test cellular responses to speciﬁc,
localized targeting of TL4 receptors.
Previous research in the neurotrauma ﬁeld has also found that, due its surfactant properties, soluble PEG can induce membrane sealing of damaged cells
and reduce edema. This has been shown to signiﬁcantly improve recovery from
both spinal cord and traumatic brain injuries by inducing cellular and behavioral recovery [Koob and Borgens, 2006, Koob et al., 2008]. In this regard, a
non-grafted dip-coated PEG ﬁlm is a technically and economically attractive
option to achieve both antifouling and membrane sealing. Our hypothesis is
that a dip-coated layer of high molecular weight PEG will exhibit suﬃcient
short term stability, simultaneously preventing adverse changes in electrical
properties of microelectrodes as well as and modulating cellular responses in
response to microelectrodes in vitro. Given the importance of the early stages
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of the injury response in shaping the later chronic stages, this approach might
prove highly beneﬁcial in vivo.

6.2

Methods

6.2.1

Cell culture and microwire placement

The experimental procedures complied with the Guide for the Care and Use
of Laboratory Animals and were approved by The Purdue Animal Care and
Use Committee (PACUC). Forebrains from E17 embryonic rat pups were received suspended in 5 mL of Solution 1 (NaCl 7.24g/L; KCl 0.4g/L; NaH2PO4
0.14g/L; Glucose 2.61g/L; Hepes 5.96g/L; MgSO4 0.295 g/L; BSA 3 g/L) in a
50 mL centrifuge tube. Under sterile conditions, the tissue was gently triturated with an added 18 µL of trypsin solution (Sigma-Aldrich, St. Louis, MO)
(7.5mg/mL in 0.9% saline). Following 20 minute incubation in a 37◦ C water
bath, 100 µL of trypsin inhibitor/DNAse solution (Sigma-Aldrich, St. Louis,
MO) (2.5 mg/mL trypsin inhibitor, 400 µg/mL DNAse in 0.9% saline) was added
and tissue was again gently triturated. The tissue was then centrifuged at 1,000
rpm for 5 minutes at room temperature and supernatant was poured oﬀ. Cells
were re-suspended in 16 mL of Hibernate-E (Brainbits, Springﬁeld, IL) and
triturated again. Cells were ﬁltered through a cell strainer and centrifuged at
1,400 rpm for 5 min at room temperature. Supernatant was poured oﬀ and
cells were re-suspended in a culture medium consisting of Dulbecco’s modiﬁed
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Eagle’s Medium (DMEM) with 10% Fetal Bovine Serum (FBS) and 10% horse
serum (HS). The cells were then seeded in 96 well plates at a density of 500,000
cells/cm2, and cultured for 7 days at 37◦ C and 5% CO2, with the cell media being replaced every 48 hours. At day 7 in vitro, lengths of 50 µm-diameter tungsten microwire (California Fine Wire Co., Grover Beach, CA) were autoclaved
then cut into small segments of 5-7 mm in length using carbide scissors. The
microwire segments were treated by dip coating with one of four treatments:
LPS (50 ng/mL) only, PEG (20% aqueous solution, 4000 MW) only, a 1:1 mixture of LPS and PEG, or uncoated. In each well, one segment of microwire was
dropped into the medium and allowed to sink to the bottom of the well. The
plates were then placed in the incubator for an additional 7 days. Figure 6.1(A)
shows wells with microwire.

6.2.2

Cell fixing and labeling

At day 14 in vitro, the cultures were ﬁxed with 4% paraformaldehyde for 10
minutes, rinsed 3x with Hepes Buﬀered Hank’s saline (HBHS) (in g/L; 7.5 g
NaCl, 0.3 g KCl, 0.06 g KH2PO4, 0.13 g Na2HPO4, 2 g Glucose, 2.4 g HEPES,
0.05 g MgCl2:6H2O, 0.05 g MgSO4:7H2O, 0.165 g CaCl2, 90 mg NaN3, at pH
7.4), then permeabilized with 0.2% Triton-X (Sigma-Aldrich, St. Louis, MO).
The cultures were then blocked with 10% normal goat serum (Jackson Immunoresearch, West Grove, PA) for 1 hour, after which primary antibodies were
added. These antibodies include beta-3-tubulin (β-3-tub) (Covance, Princeton,
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NJ), which labels neurons; Glial Fibrillary Acidic Protein (GFAP) (Millipore,
Billerica, MA), which labels astrocytes; and Ionized Calcium binding adaptor molecule 1 (Iba-1) (Wako, Osaka, Japan), and the cultures incubated in a
4◦ C refrigerator overnight. The wells were then aspirated, rinsed in HBHS 3x,
and the following secondary antibodies were added: Alexa Fluor 488 Goat antimouse, Alexa Fluor 555 Goat anti-chicken, and Alexa Fluor 635 Goat anti-rabbit
(Invitrogen, Carlsbad, CA). After a 2 hour incubation at room temperature, the
secondary antibodies were rinsed 3x with HBHS, and a ﬁnal volume of 100 µL
of HBHS was left in the wells for imaging.

6.2.3

Image acquisition and analysis:

With the microwire still attached to the bottom of the Fluorescent images of
512x512 pixels with obtained on a confocal microscope ﬁtted with a long working distance 10x air objective using Fluoview software (Olympus, Center Valley,
PA). The diﬀerent channels were imaged sequentially, and noise reduction was
achieved by applying a Kalman ﬁlter built into the acquisition software to 3
scans for each channel. Each plate was imaged using the same set of imaging parameters (laser power, aperture, acquisition time) to ensure uniformity.
Source images were imported into ImageJ (ImageJ, U. S. National Institutes
of Health, Bethesda, MD) and visually inspected and rotated to place the microwire in a vertical orientation, as shown in Figure 6.1(B). When possible, two
adjacent rectangular selections, 480 pixels high by 240 pixels wide (equivalent
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to 994 µm by 496 µm), were made with the long edge running on the center
of the microwire. If that was not possible due to excessive proximity to wall of
the well, only a single rectangular selection was made facing the interior of the
well. From these selections, intensity proﬁles of average brightness of each vertical line were generated, as shown in Figure 6.1(C). Microwire segments were
also imaged in three empty wells, and an average intensity proﬁle was obtained
and subtracted from the intensity proﬁle generated from cell-containing wells.
Three response indices (one per cell type) for each region were obtained by summing the area underneath the intensity proﬁle line between the distance points
corresponding to the deﬁned region , and dividing by 10000. Statistical analysis was performed using the SAS 9.3 statistical package (SAS Institute Inc.,
Cary, NC) . A general linear model (GLM) procedure was used perform to a one
way ANOVA with block, to remove the eﬀects of variations between the plates
by treating the plates as a statistical block. Post hoc Tukey tests were used
to determine statistical signiﬁcance between the treatment groups at a significance level of α<0.05. Plots were generated using MATLAB (The MathWorks
Inc., Natick, MA).
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Fig. 6.1. Image quantiﬁcation. Wells in 96 well plate (A) were
imaged to produce a ﬂuorescent image (B) and extract intensity
proﬁles for each channel. The ﬂuorescent image is pseudocolored to show neurons in red, astrocytes in green, and microglia
in blue. Scale bar is 50 µm. For each examined region (examples
shown within rectangles), three intensity proﬁles (C) are generated, and response indices calculated by summing the area under
the graph corresponding to the chosen distances.
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6.3

Results

6.3.1

Microglia

As shown in Figure 6.2, in the interface area containing only the microwire,
the only signiﬁcant diﬀerence in the microglial response index was between the
PEG coated microwire and LPS coated microwire (RI=1.37 vs. 2.2, p=0.007).
For the interface area containing the microwire and extending over an adjacent
25um, signiﬁcant pairwise diﬀerences were observed between the LPS coated
microwire (RI=5.84) and the other microwires (uncoated RI=4.92, p=0.041; PEG
RI=4.26, p<0.0001; LPS+PEG RI=4.82, p=0.022) . For a wider interface area
containing the microwire and extending over the adjacent 50um, these pairwise
diﬀerences get stronger between the LPS coated microwire (RI=8.27) and the
other microwires (uncoated RI=6.58, p=0.0007; PEG RI=5.8, p<0.0001; LPS+PEG
RI=6.4, p=0.0002).

Figure 6.3 shows the microglial responses at more distant regions. For the
closest distant bin extending from 50 to 150um from edge of microwire, the response index for LPS coated microwire (RI=5.62) was signiﬁcantly higher than
all the other treatments (uncoated RI=4.21, p=0.0001; PEG RI=3.71, p<0.0001;
LPS+PEG RI=3.91, p<0.0001). For the next three distant 100um wide bins,
the only signiﬁcant diﬀerence observed was between LPS coated microwire and
PEG coated microwire in all 3 bins. The calculated RI are as follows: for the bin

83

Microglia

10
9

Response index (AU)

8
7

***
*** ***

uncoated (n=16)
PEG (n=15)
LPS (n=18)
LPS+PEG (n=15)

*

6

***

*

5
4
3

*

2
1
0

Wire only

Wire+25um

Wire+50um

Interface area

Fig. 6.2. Microglia—interface. For the narrowest interface are,
the only signiﬁcant diﬀerence in the response index was between
the PEG coated microwire and LPS coated microwire. For the
wider interface areas, signiﬁcant pairwise diﬀerences were observed between the LPS coated microwire and all the other microwires. Error bars represent standard errors of the mean.
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Fig. 6.3. Microglia—distant. For the closest distant bin (50150um from edge of microwire), the response index for LPS
coated microwire was signiﬁcantly higher than all the other
treatments. For the more distant bins, the only signiﬁcant difference observed was between LPS coated microwire and PEG
coated microwire in all 3 bins. Error bars represent standard
errors of the mean.

extending from 150 to 250um from edge of microwire: LPS RI=4.5 vs. PEG 3.12,
p=0.0001; for the bin extending 250 to 350um from edge of microwire: RI= 5.12
vs. 3.8, p=0.0003; for the bin extending 350 to 450um from edge of microwire):
RI=4.98 vs. 3.9, p=0.01.

Figure 6.4 shows the astrocyte response index at interface areas. For the
interface area containing only the microwire, the astrocyte response index for
LPS coated microwire (RI=3.33) was signiﬁcantly higher than PEG coated and
LPS+PEG coated microwire (PEG RI=2.59, p=0.015; LPS+PEG RI=2.63, p=0.02).
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Fig. 6.4. Astrocytes—interface. In all examined interface areas,
the astrocyte response index for LPS coated microwire was significantly higher than PEG coated and LPS+PEG coated microwire,
but not uncoated microwire. Error bars represent standard errors of the mean.

For the interface area containing the microwire and extending an adjacent
25um, the same pairwise diﬀerence were observed, but with a stronger difference between the LPS coated microwire (RI=6.7) and the LPS+PEG coated
microwire (PEG RI=5.75, p=0.012; LPS+PEG RI=5.64, p=0.0045). For the interface area containing the microwire and extending an adjacent 50µm, the
same observation of the LPS astrocyte response index being higher than both
PEG and LPS+PEG was noticed (LPS RI=7.54, PEG RI=6.49, p=0.02; LPS+PEG
RI=6.19, p=0.002).
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Fig. 6.5. Astrocytes—distant. No signiﬁcant diﬀerences were observed between the diﬀerent treatments for the closest distant
bin. For the middle two distant bins, a slightly signiﬁcant difference was observed between LPS coated wire and LPS+PEG
coated wire. Error bars represent standard errors of the mean.

Figure 6.5 shows the astrocyte response index at distant areas. No signiﬁcant diﬀerences were observed between the diﬀerent treatments for the closest
distant bin extending from 50 to 150um from edge of microwire. For the middle two distant bins, a slightly signiﬁcant diﬀerence was observed between LPS
coated wire and LPS+PEG coated wire bin 2 (150-250um from edge of wire):
LPS RI=2.31, LPS+PEG RI=1.37, p=0.012; bin 3 (250-350um from edge of wire):
LPS RI=2.73, LPS+PEG RI=1.73, p=0.03.
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Figure 6.6 shows the neuron response index in interface(a) and distant(b)
regions, respectively. No signiﬁcant diﬀerences in the neuron response were
found between any of the treatment conditions in either interface or distant
region. In contrast to microglia and astrocytes, where the response index was
higher in distant areas in comparison to the widest interface area examined,
the neuron response index in distant areas was roughly equal to that in the
widest interface area examined.

6.4

Discussion

6.4.1

Validity of study:

To test the eﬀects of such a dip coated PEG ﬁlm on the cellular responses
to implanted electrodes, we modiﬁed a robust and frequently replicated in vitro
mixed cortical culture model pioneered by Polikov et al. [2006, 2009]. The main
drawback of in vitro models is their inability to accurately mimic in vivo microenvironments. In this particular model of primary cortical cell cultures, the
cells exist in isolation from supporting vasculature, extra-cellular brain tissue
components, and meninges. These aforementioned structures are heavily damaged during microelectrode insertion, which has been shown to strongly the
chronic response of the brain to implanted microelectrodes [Markwardt et al.,
2013, Saxena et al., 2013]. The original model developed by Polikov et al. [2006]
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Fig. 6.6. Neurons. No signiﬁcant diﬀerences in the neuron response index were observed between any of the treatments in
interface or distant areas

89
did not elicit a consistent glial scar, and it was necessary to alter the composition of the culture media to place all glial cells in the culture in an elevated
reactive state, thereby ensuring a consistent glial scar [Polikov et al., 2009]. By
coating LPS directly onto microwire, we are able to create a localized inﬂammatory microenvironment that more closely mimics the reality of an indwelling
cortical implant, rather than placing the glial cells in the culture in a globally
activated state. This localized inﬂammatory microenvironment enables us to
examine distance related eﬀects on the cultured cells. For the LPS+PEG condition, concerns about cross contamination and the potential to disrupt the dip
coated PEG ﬁlm led to the decision of codepositing PEG and LPS via dip-coating
from a single pot. Because PEG has been shown to be an excellent rapid drug
release platform [Avula et al., 2013, Craig, 2002], we were conﬁdent that our
codeposition of PEG and LPS would not hinder the exposure of the cells to LPS.
While a morphological examination of the glial cells in this model to determine the degree of activation is diﬃcult, we can infer the degree of activation
from the overall ﬂuorescence levels. Iba-1 and GFAP are upregulated in microglia and astrocytes, respectively, in the activated state. Similar image analysis approaches have been used in vitro [Achyuta et al., 2010, Polikov et al.,
2009, Tien et al., 2013] and in vivo [Azemi et al., 2011, Potter et al., 2013] to
analyze responses to microelectrodes and microscale foreign bodies.
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6.4.2

Analysis of cellular responses:

Microglia:
When examining the microglial response in a narrow interface region comprising only the area under the microwire, we observe a three tiered response;
where a signiﬁcant diﬀerence exists between the LPS only and the PEG only
treatments, but not between the other conditions. This tiered response might
be attributed to the diﬀerence between increased activation caused by the LPS
and reduced cellular adhesion caused by PEG. As the examined interface area
gets wider, we see a progressive increase in Iba-1 ﬂuorescence in response to
the LPS coated wire compared to the other treatments. This increase in Iba-1
ﬂuorescence might be explained by elevated activation of microglia through ampliﬁcation of inﬂammatory pathway precipitated by TL4 binding. The observed
elevation of Iba-1 ﬂuorescence persists in the next 100µm wide distant region,
again indicating an extended inﬂammatory response, potentially mediated by
secreted cytokines produced by activated microglia but dissipates in further
distant regions, reverting to a tiered response, where the only signiﬁcant pairwise diﬀerence is between LPS and PEG. This tiered response can again be
attributed to distinct pathway ampliﬁcation between the two treatments; the
diﬀerence appearing only between the increased upregulation of microglial activation due to LPS and the reduced microglial activation due to PEG.
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Astrocytes
In interface regions of carrying width, the astrocyte response also exhibits
a three tiered response, where an elevated astrocyte response is observed with
LPS, and a reduction occurs with both PEG conditions (with LPS and without).
In the distant regions, the ﬁrst and fourth 100um wide distant bin do not exhibit
any diﬀerences between the diﬀerent treatments, but we observe a diﬀerence
between LPS and LPS+PEG in the middle two 100um wide bins, but surprisingly no diﬀerence between LPS and PEG in these distant areas. A potential
explanation is that the astrocytes are exhibiting a dose dependent response to
LPS. Under this explanation, the increased activation in the interface area for
the LPS only treatment results in both astrocyte migration from distant regions and increased overall activation; delivering the LPS with PEG results
in astrocyte migration without an accompanying equivalent increase in activation, resulting in a depletion of distant astrocytes; while PEG only results in
even less astrocyte activation in interface areas, which in turn does not signal
migration of distant astrocytes. Because we did not directly test for whether
LPS was acting through direct binding to receptors on astrocyte surfaces, we
are merely discussing correlative eﬀects. It is unclear whether the astrocyte response is due to direct action by LPS, or if it they are reacting to cytokines and
chemokines secreted by microglia. While astrocytes are not typically thought to
express TL4 receptors, there is some evidence to the contrary [Bowman et al.,
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2003]. Additionally, while GFAP-positive astrocytes are observed in primary
cultures, a considerable portion of them diﬀerentiate in vitro from astrocyte
precursors [Abney et al., 1981]. It is possible that due to these culture conditions that the astrocyte response is altered from normally developing astrocytes
in vivo.

Neurons
No signiﬁcant diﬀerences were detected in neuron response to any of the
treatments, in either interface or distant regions. While not statistically significant, a coupling between neuron and astrocyte response can be noticed, where
slightly higher (but not signiﬁcantly diﬀerent) neuron growth was observed for
the LPS treatment. Neuronal growth has been consistently shown to occur on a
supporting substrate of astrocytes [Noble et al., 1984, Tomaselli et al., 1988]. In
contrast to the microglia and astrocytes, where the response in the widest interface bin was considerably higher than the ﬁrst adjacent distant bin, the neuron
response in that distant bin was comparable to that in the wide interface bin,
and we did not observe a decline in neuron density over distance. One explanation mirrors the concern expressed earlier about the maturity of the astrocytes,
where immature astrocytes in culture provided a better substrate for neuron
outgrowth compared to mature astrocytes [Smith et al., 1990]. An alternative
explanation is that elevated glial activation is not, in and of itself, neurotoxic or
neurodegenerative within a foreign body reactive tissue response paradigm. If
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the latter explanation is correct, then the loss of neural density in vivo following
implantation of a microelectrode might be better explained by displacement of
neurons following insertion trauma and edema which fail to reoccupy depleted
zones because of the glial scar formation, or that in vivo neurotoxicity occurs
due to direct contact between neurons and extrabrain components.

6.4.3

Conclusion

We have shown that microglial response in a primary mixed cortical culture can be manipulated by dip-coating microscale foreign bodies. Microglial
response can be increased by coating the surface of the foreign body with LPS,
and this increase can be prevented by codepositing LPS and PEG. As described
in Chapter 2, we hypothesize that the ﬁlm of high molecular weight PEG, while
allowing for LPS release, presents a hydrated physical barrier that disrupts cytokine, chemokines and adsorbed protein gradients that typically guide pathological responses. Astrocyte response also increased for LPS coated foreign
bodies, but it is unclear whether this response is directly mediated by LPS or
whether it is caused by other microglia-secreted factors. Neuron response was
not negatively correlated with microglial response, raising questions about the
mechanisms of chronic in vivo neuronal density loss .
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7. CONCLUDING REMARKS
7.1 Summary
Implantable ICMs are a promising technique for treating a wide range of
neurological deﬁciencies, but they face many challenges to becoming a viable
candidate for human clinical use. The major challenge faced by such devices
is their unreliability in chronic use. The causes of this unreliability are not
completely understood, but a major suspect is the glial scar formed around the
implanted electrode. While much research has been conducted into the progression of the reactive tissue response, no deﬁnitive solution has yet emerged.
The work presented in this dissertation highlights several important aspects
potentially salient to the progression of the reactive tissue response. Chapter
3 presented an analysis of silica sol-gel dip-coated thin-ﬁlms for intracortical
electrodes, emphasizing the need to preserve electrical properties when developing neurointegrative and bioactive coatings for intracortical microelectrodes.
Chapter 4 described the eﬀects of adsorbed protein on the electrical properties of microelectrodes, and demonstrated the utility of dip-coated high molecular weight PEG in preventing such adsorption induced changes. PEG was
also shown to reduce acute impedance increases in preliminary in vivo exper-
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iments, suggesting a role for hydrophobic molecular components in inﬂuencing impedance changes during the acute phase of the reactive tissue response.
Chapter 5 reported a method to restore electrode impedance following exposure
to a variety of solutions in vitro and to brain tissue.
While the previous chapters focused on impedance measurements in response
to exposure to protein and tissue, and approaches for prevention and cleaning,
chapter 6 examined the cellular responses to microscale foreign objects in a
primary mixed cortical cell culture model simulating localized inﬂammation
using LPS dip-coated onto the microwires. The observed responses support a
role suggested in recent literature for TL4 receptors in the reactive tissue response, but also show that neuronal density in this model is not negatively correlated with microglial activation, indicating mechanisms for neuronal density
loss other than glial activation. The results also suggest that dip-coated ﬁlms of
high molecular weight PEG have the potential to disrupt gradients of molecules
involved in the reactive tissue response.

7.2 Future Work
The results from this dissertation provide some insights to approach several
gaps in the current literature that might be of interest for future work.
The ﬁrst gap is a lack of a comprehensive understanding of the biological pathways and cascades governing the progression of the reactive tissue response. Systemically delivered drugs or drug eluting coatings requires knowl-
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edge of the biological pathway involved to ensure eﬃcient treatment. Most information about the reactive of brain cells to injury comes from the spinal cord
and traumatic brain injury literature, which while certainly relevant and important, does not have to contend with the eﬀects of a chronically indwelling
implant. It has been shown that stab wounds made with inserted electrodes do
not typically result in a glial scar compared to an implanted electrode [Biran
et al., 2005], and that a major contributor to the reactive tissue response is the
chronic injury to the blood brain barrier [Saxena et al., 2013]. Only recently
have eﬀorts been made to examine speciﬁc receptors and cytokines involved in
the reactive tissue response. TL4 receptors have been the target of several recent publications [Potter et al., 2013, Ravikumar et al., 2013], while other work
involved some investigation of upregulation of gene expression of neurotoxic cytokine transcripts using qRT-PCR [Karumbaiah et al., 2012, 2013, Saxena et al.,
2013].
A second gap involves understanding the composition of the glial scar, and
how that composition relates to the failure of implanted microelectrodes. The
typical method of assessing glial scar extent is to examine ﬂuorescence intensity
of cell surface markers associated with glial cells like microglia, astrocytes, or
oligodendrocytes. The glial scar, however, is not only composed of cells but also
of deposited extracellular matrix biomolecules, such as proteoglycans, laminin,
and collagen. As shown in this dissertation, biomolecules have a considerable
eﬀect on the properties of neural microelectrodes, and potentially on the pro-
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gression of the reactive tissue response. While a recent study by Barrese et al.
[2013] that retrospectively analyzed large sets of chronic data conﬁrmed that
the acute biological response is not necessarily correlated to electrical performance, the majority of chronic failures in that study were due to biological factors.
With the goal of identifying various extracellular proteins and receptors involved in the reactive tissue response, a systematic genomic and proteomic approach is preferable to ad hoc examinations of individual proteins or cytokines.
This might be possible by collecting slices of tissue containing the entire device and encapsulation tissue as described by Woolley et al. [2011, 2012, 2013],
and using DNA or protein microarray technologies which enable the analysis of
thousands of parameters in a single experiment [Heller, 2002, Templin et al.,
2002]. Such an approach would be an immense leap over current piecemeal
approaches if successful at identifying molecular components of the glial scar
and/or genes involved in its formation.
Another gap in the literature concerns the biphasic nature of the reactive tissue response. While consistent reports appear in the literature on the volatility
of the acute response and the intransigence of the chronic response to various
treatments, it is unclear as to why this discrepancy exists and why treatments
that aﬀect the acute response are not eﬀective against the chronic response. It is
possible that systematic genomic and proteomic data mining techniques examining the glial scar over an extended timeline might be able to shed light on this
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question. Recent reports detailing the role of transmeningeal implants [Barrese
et al., 2013, Markwardt et al., 2013, Woolley et al., 2013] suggest the importance
of migrating away from the paradigm of wired implants and towards wireless
systems. With constant advances in that ﬁeld, it is very possible that such devices might be realized in the near future. Even so, a detailed understanding of
the composition of the glial scar and the biological switches controlling the progression of the reactive tissue response are avoid designs and approaches that
would still be susceptible to degradation and failure due to the reactive tissue
response.
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